{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "# This is a sample Python script.\n",
    "# Press Shift+F10 to execute it or replace it with your code.\n",
    "# Press Double Shift to search everywhere for classes, files, tool windows, actions, and settings.\n",
    "\n",
    "\n",
    "# See PyCharm help at https://www.jetbrains.com/help/pycharm/\n",
    "import pandas as pd\n",
    "import requests\n",
    "from bs4 import BeautifulSoup as bs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[<id>35441127</id>, <id>35387044</id>, <id>35373130</id>, <id>35373125</id>, <id>35373088</id>, <id>35373072</id>, <id>35291567</id>, <id>35261474</id>, <id>35178046</id>, <id>35118329</id>, <id>35118328</id>, <id>35111162</id>, <id>35095257</id>, <id>35046939</id>, <id>35039193</id>, <id>35035559</id>, <id>35035297</id>, <id>35013735</id>, <id>35007996</id>, <id>35004791</id>]\n"
     ]
    }
   ],
   "source": [
    "search_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=COVID-19%20AND%20Merck%20AND%202020%202021[pdat]\"\n",
    "resp = requests.get(search_url).text\n",
    "bs_obj = bs(resp,features=\"lxml\")\n",
    "id_list = bs_obj.find_all(\"id\")   # idlist\n",
    "print(id_list)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<?xml version=\"1.0\" ?>\n",
      "<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2019//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd\">\n",
      "<PubmedArticleSet>\n",
      "<MedlineCitation Status=\"PubMed-not-MEDLINE\" VersionID=\"2\" VersionDate=\"2022/04/04\" Owner=\"NLM\"><PMID Version=\"2\">35441127</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">2572-4754</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>5</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Gates open research</Title><ISOAbbreviation>Gates Open Res</ISOAbbreviation></Journal><ArticleTitle>Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression.</ArticleTitle><Pagination><MedlinePgn>143</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.12688/gatesopenres.13357.2</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">SARS-CoV-2 infected individuals ≥60 years old have the highest hospitalization rates and represent &gt;80% fatalities. Within this population, those in long-term facilities represent &gt;50% of the total COVID-19 related deaths per country. Among those without symptoms, the rate of pre-symptomatic illness is unclear, and potential predictors of progression for symptom development are unknown. Our objective was to delineate the natural evolution of asymptomatic SARS-CoV-2 infection in elders and identify determinants of progression.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">We established a medical surveillance team monitoring 63 geriatric institutions in Buenos Aires, Argentina during June-July 2020. When an index COVID-19 case emerged, we tested all other eligible asymptomatic elders ≥75 or &gt;60 years old with at least 1 comorbidity. SARS-CoV-2 infected elders were followed for 28 days. Disease was diagnosed when any COVID-19 manifestation occurred. SARS-CoV-2 load at enrollment, shedding on day 15, and antibody responses were also studied.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">After 28 days of follow-up, 74/113(65%) SARS-CoV-2-infected elders remained asymptomatic. 54% of pre-symptomatic patients developed hypoxemia and ten pre-symptomatic patients died. Dementia was the only clinical risk factor associated with disease(OR 2.41(95%CI=1.08, 5.39). In a multivariable logistic regression model, dementia remained as risk factor for COVID-19 severe disease. Furthermore, dementia status showed a statistically significant different trend when assessing the cumulative probability of developing COVID-19 symptoms(log-rank p=0.027). On day 15, SARS-CoV-2 was detectable in 30% of the asymptomatic group while in 61% of the pre-symptomatic(p=0.012). No differences were observed among groups in RT-PCR mean cycle threshold at enrollment(p=0.391) and in the rates of antibody seropositivity(IgM and IgG against SARS-CoV-2).</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">In summary, 2/3 of our cohort of SARS-CoV-2 infected elders from vulnerable communities in Argentina remained asymptomatic after 28 days of follow-up with high mortality among those developing symptoms. Dementia and persistent SARS-CoV-2 shedding were associated with progression from asymptomatic to symptomatic infection.</AbstractText><CopyrightInformation>Copyright: © 2022 Esteban I et al.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Esteban</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-5196-5836</Identifier><AffiliationInfo><Affiliation>INFANT Foundation, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bergero</LastName><ForeName>Georgina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>INFANT Foundation, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Alves</LastName><ForeName>Camila</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>INFANT Foundation, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bronstein</LastName><ForeName>Micaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>INFANT Foundation, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ziegler</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>INFANT Foundation, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wood</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Militar Central, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Caballero</LastName><ForeName>Mauricio T</ForeName><Initials>MT</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-4218-5942</Identifier><AffiliationInfo><Affiliation>INFANT Foundation, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wappner</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>iTrials, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss Medical Group, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Libster</LastName><ForeName>Romina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>INFANT Foundation, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>iTrials, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Perez Marc</LastName><ForeName>Gonzalo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Militar Central, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>iTrials, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Polack</LastName><ForeName>Fernando P</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>INFANT Foundation, Buenos Aires, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>iTrials, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN=\"Y\"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.15050217.v1</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gates Open Res</MedlineTA><NlmUniqueID>101717821</NlmUniqueID><ISSNLinking>2572-4754</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19</Keyword><Keyword MajorTopicYN=\"N\">asymptomatic</Keyword><Keyword MajorTopicYN=\"N\">dementia</Keyword><Keyword MajorTopicYN=\"N\">elders</Keyword><Keyword MajorTopicYN=\"N\">geriatric institutions</Keyword><Keyword MajorTopicYN=\"N\">long-term facilities</Keyword><Keyword MajorTopicYN=\"N\">pre-symptomatic</Keyword><Keyword MajorTopicYN=\"N\">risk factors</Keyword></KeywordList><CoiStatement>Competing interests: Declaration of interests: I.E., G.B., C.A., M.B., V.Z., C.J.W., M.T.C., D.W., R.L., and G.P.M. declare no conflict of interest. FPP reports grants and non-financial support from Novavax; personal fees from Medimmune, grants and personal fees from Janssen, personal fees from Sanofi, personal fees from Bavarian Nordic, personal fees from Pfizer, personal fees from Merck, personal fees from ArkBio, personal fees from VirBio, personal fees from Regeneron, personal fees from Daiichi Sankyo, all outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>03</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>5</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35441127</ArticleId><ArticleId IdType=\"doi\">10.12688/gatesopenres.13357.2</ArticleId><ArticleId IdType=\"pmc\">PMC8987012</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JAMA Intern Med. 2020 Dec 1;180(12):1709-1711</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33074318</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32584464</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Psychiatry. 2020 Dec;7(12):1054-1063</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33031760</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32298251</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Aug 27;383(9):885-886</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32530584</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2020 Jun;26(6):845-848</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32350462</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):923-929</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32673298</ArticleId></ArticleIdList></Reference><Reference><Citation>Virulence. 2020 Dec;11(1):1006-1014</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32722990</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 2020 Sep;68(9):1895-1898</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32501537</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2021 Feb 12;16(2):e0246903</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33577582</ArticleId></ArticleIdList></Reference><Reference><Citation>Respir Med. 2020 Aug;169:106026</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32513410</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2021 Feb;93(2):916-923</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32710669</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Intern Med. 2020 Nov 1;180(11):1447-1452</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32780793</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Immunol. 2020 Dec 22;5(54):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33443036</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2021 Feb;93(2):820-830</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32691881</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Public Health. 2020 Dec;13(12):1833-1839</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32788073</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2224-2230</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32687551</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2021 Feb 18;384(7):610-618</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33406353</ArticleId></ArticleIdList></Reference><Reference><Citation>Aging (Albany NY). 2020 Jun 19;12(12):11238-11244</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32561692</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2021 Mar;27(3):928-931</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33350923</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):1269-1274</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32515684</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2020 Jul 1;3(7):e2015957</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32697325</ArticleId></ArticleIdList></Reference><Reference><Citation>Aging Clin Exp Res. 2020 Dec;32(12):2695-2701</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33034016</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2021 Feb 2;12(1):740</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33531472</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2021 Mar;93(3):1449-1458</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32790106</ArticleId></ArticleIdList></Reference><Reference><Citation>J Microbiol Immunol Infect. 2021 Feb;54(1):12-16</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32425996</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35387044</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">2673-6101</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>2</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in allergy</Title><ISOAbbreviation>Front Allergy</ISOAbbreviation></Journal><ArticleTitle>Review: The Nose as a Route for Therapy. Part 2 Immunotherapy.</ArticleTitle><Pagination><MedlinePgn>668781</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/falgy.2021.668781</ELocationID><Abstract><AbstractText>The nose provides a route of access to the body for inhalants and fluids. Unsurprisingly it has a strong immune defense system, with involvement of innate (e.g., epithelial barrier, muco- ciliary clearance, nasal secretions with interferons, lysozyme, nitric oxide) and acquired (e.g., secreted immunoglobulins, lymphocytes) arms. The lattice network of dendritic cells surrounding the nostrils allows rapid uptake and sampling of molecules able to negotiate the epithelial barrier. Despite this many respiratory infections, including SARS-CoV2, are initiated through nasal mucosal contact, and the nasal mucosa is a significant \"reservoir\" for microbes including <i>Streptococcus pneumoniae, Neisseria meningitidis and SARS -CoV-2</i>. This review includes consideration of the augmentation of immune defense by the nasal application of interferons, then the reduction of unnecessary inflammation and infection by alteration of the nasal microbiome. The nasal mucosa and associated lymphoid tissue (nasopharynx-associated lymphoid tissue, NALT) provides an important site for vaccine delivery, with cold-adapted live influenza strains (LAIV), which replicate intranasally, resulting in an immune response without significant clinical symptoms, being the most successful thus far. Finally, the clever intranasal application of antibodies bispecific for allergens and Intercellular Adhesion Molecule 1 (ICAM-1) as a topical treatment for allergic and RV-induced rhinitis is explained.</AbstractText><CopyrightInformation>Copyright © 2021 Padayachee, Flicker, Linton, Cafferkey, Kon, Johnston, Ellis, Desrosiers, Turner, Valenta and Scadding.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Padayachee</LastName><ForeName>Yorissa</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Faculty of Medicine, Imperial College Healthcare NHS Trust, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Flicker</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Linton</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, Department of Medicine, Queen's University, Kingston, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Allergy Research Unit, Kingston Health Sciences Centre (KHSC), Kingston, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cafferkey</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Faculty of Medicine, Imperial College Healthcare NHS Trust, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kon</LastName><ForeName>Onn Min</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Johnston</LastName><ForeName>Sebastian L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ellis</LastName><ForeName>Anne K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, Department of Medicine, Queen's University, Kingston, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Desrosiers</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngologie, The University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Turner</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Valenta</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Immunopathology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Scadding</LastName><ForeName>Glenis Kathleen</ForeName><Initials>GK</Initials><AffiliationInfo><Affiliation>Royal National Ear Nose and Throat Hospital, University College London Hospitals NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infection and Immunity, Faculty of Medical Sciences, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Allergy</MedlineTA><NlmUniqueID>9918227355906676</NlmUniqueID><ISSNLinking>2673-6101</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">ICAM-1</Keyword><Keyword MajorTopicYN=\"N\">allergen immunotherapy</Keyword><Keyword MajorTopicYN=\"N\">allergen-specific antibody</Keyword><Keyword MajorTopicYN=\"N\">epithelial barrier</Keyword><Keyword MajorTopicYN=\"N\">interferon</Keyword><Keyword MajorTopicYN=\"N\">microbiome</Keyword><Keyword MajorTopicYN=\"N\">rhinovirus</Keyword><Keyword MajorTopicYN=\"N\">vaccination</Keyword></KeywordList><CoiStatement>AE has participated in advisory boards for ALK Abello, AstraZeneca, Aralez, Bausch Health, Circassia Ltd, GlaxoSmithKline, Johnson &amp; Johnson, Merck, Mylan, Novartis, Pediapharm and Pfizer, has been a speaker for ALK, Aralez, AstraZeneca, Boerhinger-Ingelheim, CACME, Meda, Mylan, Merck, Novartis, Pediapharm, Pfizer, The ACADEMY, and Takeda. Her institution has received research grants from Bayer LLC, Circassia Ltd, Green Cross Pharmaceuticals, GlaxoSmithKline, Sun Pharma, Merck, Novartis, Pfizer, Regeneron and Sanofi. She has also served as an independent consultant to Allergy Therapeutics, Bayer LLC, Ora Inc. and Regeneron in the past. GS reports fees and consultancies from ALK, Mylan, Bayer, GSK outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>02</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>05</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>4</Month><Day>7</Day><Hour>5</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35387044</ArticleId><ArticleId IdType=\"doi\">10.3389/falgy.2021.668781</ArticleId><ArticleId IdType=\"pmc\">PMC8974912</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sci Rep. 2018 Jul 26;8(1):11245</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30050168</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Allergy. 2003 Sep;33(9):1198-208</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12956739</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinology. 1999 Sep;37(3):97-103</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10567986</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2006 Oct;6(10):761-71</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16998509</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Allergy. 2017 May;47(5):665-674</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28165640</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2017 Oct;140(4):1187-1191</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28532654</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2021 Mar 30;12(1):1967</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33785743</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy Asthma Clin Immunol. 2011 Dec 06;7:20</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22145744</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy. 2015 Aug;70(8):910-20</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25858686</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13562-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18768794</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2007 Mar;14(3):226-33</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17202306</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2014 Nov 5;312(17):1772-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25322359</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2021 Feb 11;384(6):497-511</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33264556</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14677-82</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15310844</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1990 Dec 6;348(6301):552-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2247164</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2018 Jan;103(1):101-105</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28855230</ArticleId></ArticleIdList></Reference><Reference><Citation>J Interferon Res. 1988 Oct;8(5):591-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2853194</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Res. 2020 May 8;2020:1372494</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32455136</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1975 Aug 7;256(5517):495-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1172191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 May 30;395(10238):1695-1704</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32401715</ArticleId></ArticleIdList></Reference><Reference><Citation>Transl Res. 2017 Jan;179:7-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27513210</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1986 Jan 9;314(2):71-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3001519</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Nutr Metab. 2012;61(2):160-74</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23037511</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Cell Infect Microbiol. 2020 Oct 12;10:440</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33154953</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2002 Aug;32(8):2156-62</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12209627</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 1994 May;7(1):13-21</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8075633</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1987 Aug;156(2):379-83</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3598236</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2003 Dec 8;22(1):87-95</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14604575</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy Asthma Clin Immunol. 2006 Sep 15;2(3):117-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20525156</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(12):e29255</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22220209</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2018 Apr 12;9(1):1421</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29650949</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20889904</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacokinet. 1990 Nov;19(5):390-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1702693</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 1983 Nov;24(5):713-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6318655</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2000 Oct 1;165(7):3849-59</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11034391</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2013 Jun;131(6):1479-90</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23587334</ArticleId></ArticleIdList></Reference><Reference><Citation>Biotechnology (N Y). 1995 Aug;13(8):779-86</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9634808</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1986 Aug 21;315(8):513-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3736634</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Arch Allergy Immunol. 2020;181(2):128-135</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31805564</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 1989 Mar;33(3):387-90</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2543280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1973 Mar 17;1(7803):563-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">4120640</ArticleId></ArticleIdList></Reference><Reference><Citation>J Interferon Res. 1986 Apr;6(2):153-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3014018</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Respir J. 2013 Apr;7(2):168-75</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22621438</ArticleId></ArticleIdList></Reference><Reference><Citation>Respir Res. 2016 Nov 21;17(1):156</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27871304</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2015 May 13;17(5):592-602</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25974301</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2008 May;121(5):1126-1132.e7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18367240</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2020 May 26;31(8):107674</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32460009</ArticleId></ArticleIdList></Reference><Reference><Citation>Laryngoscope. 2003 Jul;113(7):1199-205</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12838019</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2015 Sep 1;195(5):1909-10</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26297789</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Aug;82(16):8059-70</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18524813</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5153-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24706856</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 1976 Apr;57(4):335-41</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">57128</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2006 Sep;12(9):1023-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16906156</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Med. 2021 Dec;53(1):391-401</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33620016</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy. 2017 Aug;72(8):1156-1173</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28152201</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2020 Oct;99:84-91</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32758689</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2020 May 15;11:1061</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32574262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2001 Oct 6;358(9288):1129-33</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11597666</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Arch Allergy Immunol. 2015;166(4):291-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26044772</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 1983 Aug;3(2):121-36</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6312877</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 1988 Feb;32(2):224-30</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2834996</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmaceuticals (Basel). 2010 Jan 28;3(2):323-344</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27713254</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Allergy Clin Immunol. 2020 Feb;20(1):30-35</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31789894</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1991 Aug 15;352(6336):624-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1907718</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2021 Apr;105:516-521</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33713817</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1996 May 3;271(18):10967-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmaceuticals (Basel). 2010 Apr 20;3(4):1162-1186</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27713294</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2007 Apr;119(4):1019-21</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17289135</ArticleId></ArticleIdList></Reference><Reference><Citation>Biofactors. 2009 Jan-Feb;35(1):14-20</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19319841</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Immunol. 2018;138:195-256</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29731005</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Med Chem. 2021;21(10):920-927</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33970846</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2011 May;127(5):1148-54.e9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21329968</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Arch Allergy Immunol. 1998 Feb;115(2):157-61</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9482705</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2012 Sep 12;4(151):151ra124</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22972842</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Arch Allergy Immunol. 2009;150(1):25-31</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19339799</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Sep 29;8:1232</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29033947</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinology. 2012 Mar;50(1):1-12</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22469599</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2011 Aug;10(8):1131-41</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21854309</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Jul 26;362(9380):293-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12892961</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy. 2014 Apr;69(4):517-26</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24611950</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Allergy. 2007 Mar;37(3):348-57</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17359385</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 May 28;181(5):1016-1035.e19</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2011 Jul;7(7):e1002114</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21779162</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2020 Oct 12;11(1):5139</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33046696</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Allergy. 2004 Apr;34(4):654-62</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15080822</ArticleId></ArticleIdList></Reference><Reference><Citation>Laryngoscope Investig Otolaryngol. 2017 Nov 08;2(6):410-416</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29299516</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Oct 5;355(14):1445-55</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17021320</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2017 Jan 2;13(1):34-45</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27936348</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2018 Oct 30;67(10):1603-1609</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29659748</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):317-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15030704</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2003 Jan 17;21(5-6):549-61</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12531655</ArticleId></ArticleIdList></Reference><Reference><Citation>MEDICC Rev. 2021 Apr;23(2):10</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33974608</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy. 2017 Dec;72(12):1849-1858</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28543717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1982 Jul 24;2(8291):186-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6177991</ArticleId></ArticleIdList></Reference><Reference><Citation>J Zhejiang Univ Sci B. 2020 Aug.;21(8):628-636</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32748578</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Lett. 2017 Sep;189:19-26</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28472641</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Dermatol. 2015 Aug 01;15:13</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26232126</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccines (Basel). 2020 Jun 18;8(2):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32570763</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1999 Sep 1;163(5):2944-52</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10453043</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Paediatr. 1997 Sep;86(9):956-61</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9343275</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1993 Oct;168(4):881-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8376833</ArticleId></ArticleIdList></Reference><Reference><Citation>EBioMedicine. 2020 Apr;54:102734</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32279057</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vet Intern Med. 2018 Jan;32(1):9-25</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29171095</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1989 Nov 18;299(6710):1259-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2513902</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 2018 Mar 22;86(4):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29426044</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Dis Clin North Am. 2011 Dec;25(4):819-34</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22054758</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Forum Allergy Rhinol. 2017 Mar;7(3):230-239</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27879060</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Cell Mol Biol. 2016 Jul;55(1):117-27</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26807508</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 Jan 22;457(7228):480-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19043404</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Microbiol. 2017 Jan;19(1):381-392</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27902866</ArticleId></ArticleIdList></Reference><Reference><Citation>Molecules. 2019 Jan 31;24(3):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30708992</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2011 Nov;52(3):215-21</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21880543</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2016 Nov;65(11):1906-1915</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27531828</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2021 Apr 13;11(1):8059</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33850184</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Endosc. 2019 Mar;52(2):137-143</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30909689</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy Rhinol (Providence). 2020 Mar 13;11:2152656720911605</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32206384</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2019 Mar;143(3):1258-1261</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30471304</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2012 Jun;129(6):1506-1514.e6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22657407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1983 Oct 22;2(8356):962</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6138515</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1989 Oct;160(4):700-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2551976</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy Asthma Proc. 2013 Jul-Aug;34(4):328-34</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23883597</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunopharmacol. 2020 Nov;88:106903</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32862111</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2021 May;9(5):498-510</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33556319</ArticleId></ArticleIdList></Reference><Reference><Citation>World Allergy Organ J. 2020 Apr 29;13(5):100118</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32373267</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Allergy Asthma Rep. 2015 Jul;15(7):41</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26143392</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugs. 1991 Nov;42(5):749-65</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1723372</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2014 Jul 15;190(2):145-54</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24937476</ArticleId></ArticleIdList></Reference><Reference><Citation>Otolaryngol Head Neck Surg. 2011 May;144(5):802-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21493366</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 1984 Jul;26(1):31-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6089652</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Rhinol Allergy. 2014 Jul-Aug;28(4):281-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25197913</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy. 2019 Jan;74(1):100-110</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29888398</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Hypotheses. 2020 Nov;144:109802</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32526507</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med J (Clin Res Ed). 1982 Jun 19;284(6332):1822-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6177374</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2013;9(8):e1003520</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23935498</ArticleId></ArticleIdList></Reference><Reference><Citation>Probiotics Antimicrob Proteins. 2019 Dec;11(4):1219-1226</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30535674</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Allergy. 1999 Mar;29(3):342-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10202341</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 1993 Mar;91(3):783-92</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8095941</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2019 Oct 11;15(10):e1008072</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31603951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Allergy Asthma Immunol. 2013 Nov;111(5):397-401</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24125148</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Cell Infect Microbiol. 2018 May 15;8:150</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29868506</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Allergy. 1998 Apr;28(4):404-12</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9641566</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Jan 31;368(5):407-15</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23323867</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Lett. 2009 Jan 29;122(1):1-11</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19059436</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Microbiol. 2010 Dec 09;10:316</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21143932</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 1998 Aug 1;83(3):482-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9690541</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO Mol Med. 2016 Sep 01;8(9):1099-112</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27520969</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):312-3</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25754723</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2015 Aug;136(2):490-3.e11</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25769914</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2020 Jun 10;70(12):2505-2513</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31642899</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11070-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16033867</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Invest. 2008 Apr;38(4):260-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18339006</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2019 Feb;143(2):591-603.e3</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29935218</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Oct 18;449(7164):804-10</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17943116</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2003 Jan;123(1):209-16</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12527624</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Forum Allergy Rhinol. 2017 Jun;7(6):561-569</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28481057</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2012 Nov;130(5):1049-62</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23040884</ArticleId></ArticleIdList></Reference><Reference><Citation>J Microencapsul. 2004 Nov;21(7):761-74</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15799226</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Pediatr Otorhinolaryngol. 2002 Jan 11;62(1):17-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11738689</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1935 Nov 30;62(6):733-50</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19870445</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharm. 1983 Jan-Feb;2(1):20-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6192965</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(10):e25880</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21998712</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Arch Allergy Immunol. 2014;163(1):43-50</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24247974</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1980 Sep;77(9):5429-31</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6159646</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13780-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17699621</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2075-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26205666</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Allergy. 1976 Aug;37(2):91-100</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">987744</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Allergy Asthma Rep. 2017 Sep;17(9):59</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28785927</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy. 2017 Nov;72(11):1657-1665</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28474799</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy. 2006 Jul;61(7):812-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16792578</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Struct Biol. 2014 Aug;27:102-12</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25033247</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1994 Apr 28;368(6474):856-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8159246</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1996 Jul 15;157(2):956-62</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8752951</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 1990 Jul;14(1):3-10</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2080867</ArticleId></ArticleIdList></Reference><Reference><Citation>Cytokine Growth Factor Rev. 2014 Aug;25(4):369-76</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25156421</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):579-91</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9802365</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Allergy. 2014 Nov;44(11):1409-19</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25262820</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbes Infect. 2005 Mar;7(3):569-78</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15792636</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2013 Oct;10(10):e1001527</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24115913</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 1994 Oct;94(4):738-46</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7930308</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1983 Sep;148(3):543-50</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6311914</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17994-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19004758</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2007 Jan;119(1):192-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17208601</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2011 May;89(5):685-95</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21233408</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1984 Aug;150(2):174-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6381610</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2004 Mar;10(3):290-3</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14981511</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1986 Jan 9;314(2):65-70</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3001518</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2004 Apr 1;189(7):1164-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15031783</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2003 Jan;4(1):69-77</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12483210</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy. 2009 Mar;64(3):375-86</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19175599</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2018 Nov;142(5):1656-1659.e9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30059698</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Dis Child. 2009 Feb;94(2):92-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18713796</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1977 Sep 29;269(5627):420-2</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">198669</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 1983 Jan;71(1 Pt 1):71-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6337198</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):358-64</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8306030</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2005 Aug;116(2):347-54</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16083789</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24912386</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc R Soc Lond B Biol Sci. 1957 Sep 12;147(927):258-67</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">13465720</ArticleId></ArticleIdList></Reference><Reference><Citation>Allergy. 2012 Mar;67(3):371-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22423374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2021 Feb;9(2):196-206</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33189161</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 2001 Jan;107(1):105-13</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11149999</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Nov 19;8(11):e80702</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24260458</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1989 Dec 8;246(4935):1275-81</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2531466</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1986 Jul;154(1):128-33</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3011917</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2018 Mar 1;197(5):673-675</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28862881</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunotherapy. 2012 Feb;4(2):201-12</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22339462</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 1993 May;91(5):987-96</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8491949</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2021 Jun 2;13(596):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2005 Mar 21;201(6):937-47</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15781584</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1988 Jul;158(1):166-75</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2839579</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hematol. 2003 May;73(1):54-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12701122</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Forum Allergy Rhinol. 2016 Sep;6(9):956-63</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27080343</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Rhinol Allergy. 2016 Sep 1;30(5):157-175</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27442711</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1984 Aug;150(2):181-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6381611</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5147-52</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24706858</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2020 Aug 20;64(9):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32661006</ArticleId></ArticleIdList></Reference><Reference><Citation>J Allergy Clin Immunol. 1981 Jul;68(1):33-40</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7240598</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"MEDLINE\" IndexingMethod=\"Automated\" Owner=\"NLM\"><PMID Version=\"1\">35373130</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">2641-7650</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>24</Day></PubDate></JournalIssue><Title>Kidney360</Title><ISOAbbreviation>Kidney360</ISOAbbreviation></Journal><ArticleTitle>COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry.</ArticleTitle><Pagination><MedlinePgn>293-306</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.34067/KID.0006612021</ELocationID><Abstract><AbstractText Label=\"Background\" NlmCategory=\"UNASSIGNED\">The acute and long-term effects of severe acute respiratory syndrome coronavirus 2 infection in individuals with GN are still unclear. To address this relevant issue, we created the International Registry of COVID-19 infection in GN.</AbstractText><AbstractText Label=\"Methods\" NlmCategory=\"UNASSIGNED\">We collected serial information on kidney-related and -unrelated outcomes from 125 GN patients (63 hospitalized and 62 outpatients) and 83 non-GN hospitalized patients with coronavirus disease 2019 (COVID-19) and a median follow-up period of 6.4 (interquartile range 2.3-9.6) months after diagnosis. We used logistic regression for the analyses of clinical outcomes and linear mixed models for the longitudinal analyses of eGFR. All multiple regression models were adjusted for age, sex, ethnicity, and renin-angiotensin-aldosterone system inhibitor use.</AbstractText><AbstractText Label=\"Results\" NlmCategory=\"UNASSIGNED\">After adjustment for pre-COVID-19 eGFR and other confounders, mortality and AKI did not differ between GN patients and controls (adjusted odds ratio for AKI=1.28; 95% confidence interval [CI], 0.46 to 3.60; <i>P</i>=0.64). The main predictor of AKI was pre-COVID-19 eGFR (adjusted odds ratio per 1 SD unit decrease in eGFR=3.04; 95% CI, 1.76 to 5.28; <i>P</i>&lt;0.001). GN patients developing AKI were less likely to recover pre-COVID-19 eGFR compared with controls (adjusted 6-month post-COVID-19 eGFR=0.41; 95% CI, 0.25 to 0.56; times pre-COVID-19 eGFR). Shorter duration of GN diagnosis, higher pre-COVID-19 proteinuria, and diagnosis of focal segmental glomerulosclerosis or minimal change disease were associated with a lower post-COVID-19 eGFR.</AbstractText><AbstractText Label=\"Conclusions\" NlmCategory=\"UNASSIGNED\">Pre-COVID-19 eGFR is the main risk factor for AKI regardless of GN diagnosis. However, GN patients are at higher risk of impaired eGFR recovery after COVID-19-associated AKI. These patients (especially those with high baseline proteinuria or a diagnosis of focal segmental glomerulosclerosis or minimal change disease) should be closely monitored not only during the acute phases of COVID-19 but also after its resolution.</AbstractText><CopyrightInformation>Copyright © 2022 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Waldman</LastName><ForeName>Meryl</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kidney Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Soler</LastName><ForeName>Maria Jose</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Servei Nefrologia, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grup de Recerca de Nefrología, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>García-Carro</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servei Nefrologia, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grup de Recerca de Nefrología, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lightstone</LastName><ForeName>Liz</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-4603-4076</Identifier><AffiliationInfo><Affiliation>Centre for Inflammatory Disease, Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Imperial College Healthcare NHS Trust Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Turner-Stokes</LastName><ForeName>Tabitha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centre for Inflammatory Disease, Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Imperial College Healthcare NHS Trust Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Griffith</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Imperial College Healthcare NHS Trust Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Torras</LastName><ForeName>Joan</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-1135-7588</Identifier><AffiliationInfo><Affiliation>Nephrology Department, Bellvitge University Hospital, Clinical Science Department, Barcelona University, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Martinez Valenzuela</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Nephrology Department, Bellvitge University Hospital, Clinical Science Department, Barcelona University, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bestard</LastName><ForeName>Oriol</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Servei Nefrologia, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grup de Recerca de Nefrología, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Geddes</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Glasgow Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Flossmann</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0001-5976-3609</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Royal Berkshire Hospital, Reading, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Budge</LastName><ForeName>Kelly L</ForeName><Initials>KL</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-9929-8518</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Renal Division, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cantarelli</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Dipartimento di Medicina e Chirurgia, Università di Parma, UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fiaccadori</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dipartimento di Medicina e Chirurgia, Università di Parma, UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Delsante</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-0715-6764</Identifier><AffiliationInfo><Affiliation>Dipartimento di Medicina e Chirurgia, Università di Parma, UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Morales</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-5824-6973</Identifier><AffiliationInfo><Affiliation>Departamento de Nefrología, Hospital Universitario 12 de Octubre/Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gutierrez</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Nefrología, Hospital Universitario 12 de Octubre/Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Niño-Cruz</LastName><ForeName>Jose A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Departamento de Nefrología y Metabolismo Mineral Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Martinez-Rueda</LastName><ForeName>Armando J</ForeName><Initials>AJ</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0001-5765-4521</Identifier><AffiliationInfo><Affiliation>Departamento de Nefrología y Metabolismo Mineral Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Comai</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Experimental Diagnostic and Specialty Medicine (DIMES), Nephrology, Dialysis and Renal Transplant Unit, IRCCS-Azienda Ospedaliero-Universitaria de Bologna, Alma Mater Studiorum University of Bologna, Italy, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bini</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Experimental Diagnostic and Specialty Medicine (DIMES), Nephrology, Dialysis and Renal Transplant Unit, IRCCS-Azienda Ospedaliero-Universitaria de Bologna, Alma Mater Studiorum University of Bologna, Italy, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>La Manna</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Experimental Diagnostic and Specialty Medicine (DIMES), Nephrology, Dialysis and Renal Transplant Unit, IRCCS-Azienda Ospedaliero-Universitaria de Bologna, Alma Mater Studiorum University of Bologna, Italy, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Slon</LastName><ForeName>Maria F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Manrique</LastName><ForeName>Joaquin</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-7713-1629</Identifier><AffiliationInfo><Affiliation>Hospital Universitario de Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Avello</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-9987-0588</Identifier><AffiliationInfo><Affiliation>Red de Investigación Renal (REDINREN), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nephrology and Hypertension, Fundación Instituto de Investigación Sanitaria-Fundación Jiménez Díaz-Universidad Autónoma Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fernandez-Prado</LastName><ForeName>Raul</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-5201-1137</Identifier><AffiliationInfo><Affiliation>Red de Investigación Renal (REDINREN), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nephrology and Hypertension, Fundación Instituto de Investigación Sanitaria-Fundación Jiménez Díaz-Universidad Autónoma Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ortiz</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Red de Investigación Renal (REDINREN), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nephrology and Hypertension, Fundación Instituto de Investigación Sanitaria-Fundación Jiménez Díaz-Universidad Autónoma Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Marinaki</LastName><ForeName>Smaragdi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinic of Nephrology and Renal Transplantation, NKUA, Medical School, Laiko General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Martin Varas</LastName><ForeName>Carmen Rita</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Servicio de Nefrología, Hospital General de Segovia, Segovia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rabasco Ruiz</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Universitario Reina Sofía, Cordoba, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sierra-Carpio</LastName><ForeName>Milagros</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital San Pedro, Logroño La Rioja, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>García-Agudo</LastName><ForeName>Rebeca</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-0649-2766</Identifier><AffiliationInfo><Affiliation>Nephrology Department La Mancha-Centro Hospital, Alcázar de San Juan, Ciudad Real, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fernández Juárez</LastName><ForeName>Gema</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Nephrology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hamilton</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-0730-4897</Identifier><AffiliationInfo><Affiliation>Renal Unit, Royal Devon and Exeter NHS Foundation Trust, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bruchfeld</LastName><ForeName>Annette</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine, Karolinska University Hospital and CLINTEC Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chrysochou</LastName><ForeName>Constantina</ForeName><Initials>C</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-1966-5558</Identifier><AffiliationInfo><Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Howard</LastName><ForeName>Lilian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Kidney Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sinha</LastName><ForeName>Smeeta</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-4117-4085</Identifier><AffiliationInfo><Affiliation>Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Leach</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Agraz Pamplona</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Servei Nefrologia, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grup de Recerca de Nefrología, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maggiore</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-7468-9600</Identifier><AffiliationInfo><Affiliation>Dipartimento di Medicina e Chirurgia, Università di Parma, UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cravedi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0001-7837-0923</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Renal Division, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Kidney360</MedlineTA><NlmUniqueID>101766381</NlmUniqueID><ISSNLinking>2641-7650</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D058186\" MajorTopicYN=\"Y\">Acute Kidney Injury</DescriptorName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"Y\">COVID-19</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005500\" MajorTopicYN=\"N\">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012042\" MajorTopicYN=\"N\">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086402\" MajorTopicYN=\"N\">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19</Keyword><Keyword MajorTopicYN=\"N\">follow-up studies</Keyword><Keyword MajorTopicYN=\"N\">glomerular and tubulointerstitial diseases</Keyword><Keyword MajorTopicYN=\"N\">glomerular disease</Keyword><Keyword MajorTopicYN=\"N\">kidney glomerulus</Keyword><Keyword MajorTopicYN=\"N\">registries</Keyword></KeywordList><CoiStatement>O. Bestard reports patents and inventions with Oxford Immunotec and is associate editor of Transplant International and Frontiers in Immunology. A. Bruchfeld reports consultancy agreements with AstraZeneca, Chemocentryx, Fresenius, and Merck; a research grant from AstraZeneca; honoraria from Bayer, Chemocentryx, Fresenius, Merck, and Vifor; and is a member of the ERA-EDTA scientific advisory board 2018–2024, chair of the ERA-EDTA Immunonephrology Working Group, and vice-chair of the Swedish Renal Fund. G. Comai reports honoraria from Alexion, Astellas, and Novartis. P. Cravedi reports honoraria as an advisor for Chinook Therapeutics and is associate editor for the Journal of Nephrology and the American Journal of Transplantation. G. Fernandez Juarez reports research funding from Instituto Salud Calos III and honoraria from Alexion and GSK. E. Fiaccadori is on the editorial board of the Journal of Nephrology and Blood Purification and is a member of the Italian Society of Nephrology and the European Society of Parenteral and Enteral Nutrition. O. Flossmann reports consultancy agreements with Vifor Pharma has other interests/relationships with the British Medical Association, European Vasculitis Society, Renal Association (UK), Royal College of Physicians London, and UK Ireland Vasculitis Society. C. García-Carro reports consultancy agreements with Astellas, AstraZeneca, Boehringer Ingelheim Lilly, Esteve, Novartis and Baxter, Novo Nordisk, and Otsuka; honoraria from Astellas, AstraZeneca, Boehringer Ingelheim Lilly, Esteve, Novartis and Baxter, Novo Nordisk, and Otsuka; and is a scientific advisor for or member of AstraZeneca, Boehringer Ingelheim Lilly, Mundipharma, and Novo Nordisk. M. Griffith reports honoraria from Retrophin’s advisory board. A. J. Hamilton is on the editorial board of the Journal of Kidney Care and is a member of the SONG-Kids Life Participation Expert Working Group. T. Leach reports honoraria from Janssen for conference attendance in 2012 and is a scientific advisor to the National Institute for Health and Care Excellence. L. Lightstone reports consultancy agreements with Achillion, Alexion, AstraZeneca, Aurinia, BMS, GSK, Kezar, Novartis, Pfizer, and Roche; honoraria from Alexion, AstraZeneca, BMS, GSK, and Pfizer; is a scientific advisor or member of EU Exec Lupus Nephritis Trials Network; is on the advisory board of Nature Reviews Nephrology; participates in a speakers’ bureau for Alexion and GSK; is a trustee of Kidney Research UK 2018–2022; is an executive member of the International Society of Nephrology 2021–2023; is deputy chair of Western Regional Board of the International Society of Nephrology; and is a clinical expert representing the Renal Association response to NICE on STA for belimumab in lupus 2020–2021. U. Maggiore reports consultancy agreements with Biotest, Chiesi, GSK, Hansa, Novartis, Sandoz, and Takeda. J. Manrique is a scientific advisor for or member of AstraZeneca, Boehringer, and Viphor Pharma. E. Morales reports consultancy agreements with Alexion, Celgene, Viphor Fresenius, and Vifor Pharma. J.A. Niño-Cruz reports research funding from Pfizer Scientific Institute and participates in a speakers’ bureau for Takeda and Roche. A. Ortiz reports consultancy agreements with Retrophin and Sanofi Genzyme; research funding from AstraZeneca, Mundipharma, and Sanofi Genzyme; honoraria from Advicciene, Alexion, Amgen, Amicus, Astellas, AstraZeneca, Bayer, Chiesi, Fresenius Medical Care, Idorsia, Kyowa Kirin, Menarini, Otsuka, Sanofi Genzyme, and Vifor Fresenius Medical Care Renal Pharma; is a member of the Spanish Society of Nephrology; is editor-in-chief of the Clinical Kidney Journal; is on the editorial boards of the Journal of Nephrology, Journal of the American Society of Nephrology, and Peritoneal Dialysis International; is a member of SOMANE and ERA Councils; is on the board of directors for IIS-Fundacion Jimenez Diaz UAM; is on the scientific advisory board of the Dutch Kidney Foundation; honoraria listed above are for speaker engagements: Advicciene, Alexion, Astellas, AstraZeneca, Amicus, Amgen, Bayer, Chiesi, Fresenius Medical Care, Idorsia, Kyowa Kirin, Menarini, Otsuka, Sanofi Genzyme, and Vifor Fresenius Medical Care Renal Pharma. S. Sinha reports consultancy agreements with Sanifit; research funding from Amgen, AstraZeneca, and Ethicon; and honoraria from AstraZeneca, Bayer, Napp Pharmaceuticals, Novartis, and Sanofi Genzyme. M.F. Slon-Roblero reports consultancy agreements with Baxter, Fresenius, and Nipro; and honoraria from Baxter, Fresenius, and Nipro. M.J. Soler reports consultancy agreements with AstraZeneca, Bayer, Boehringer, Esteve, Jansen, Mundipharma, Novo Nordisk, Travere, and ICU; research funding from Abbvie and Boehringer; honoraria from AstraZeneca, Boehringer, Esteve, FMC, Jansen, ICU Medical, Mundipharma, Novo Nordisk, Otsuka, and Travere; patents and inventions: U691ES00; is a scientific advisor for or member of BMC Nephrology and Clinical Kidney Journal; is a former member of ERA-EDTA Council; participates in a speakers’ bureau for AstraZeneca, Bayer, Boehringer, Esteve, FMC, Jansen, Mundipharma, Novo Nordisk, and Vifor; is a member of the Sociedad Española de Nefrología and Sociedad Catalana de Nefrologia; and is elected editor-in-chief of the Clinical Kidney Journal. All remaining authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>4</Month><Day>4</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35373130</ArticleId><ArticleId IdType=\"doi\">10.34067/KID.0006612021</ArticleId><ArticleId IdType=\"pii\">K3602021000661</ArticleId><ArticleId IdType=\"pmc\">PMC8967646</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Kidney Dis. 2021 Feb;77(2):204-215.e1</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32961245</ArticleId></ArticleIdList></Reference><Reference><Citation>Transplantation. 2021 Sep 1;105(9):e104-e106</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34049360</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Neurol. 2021 Jun 1;78(6):699-708</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33739362</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2015 Oct;66(4):602-12</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25975964</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2021 Nov;174(11):1572-1585</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34461029</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2021 Aug 12;385(7):661-662</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34161700</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2020 Dec 1;3(12):e2029058</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33301018</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2021 Jul 9;16(7):e0254525</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34242368</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2020 Oct 7;15(10):1494-1495</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32718953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephrol Dial Transplant. 2021 Jan 1;36(1):87-94</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33340043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2020 Jul;79(7):859-866</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32471903</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Dec 18;376(9758):2096-103</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21094997</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathog Immun. 2021 May 14;6(1):76-103</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34056149</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2021 Jul;80(7):930-942</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33504483</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2021 Nov;32(11):2851-2862</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>EClinicalMedicine. 2020 Nov;28:100591</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33078138</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Med (Lausanne). 2021 May 25;8:678200</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34113640</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Relat Disord. 2020 Nov;46:102472</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32890817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2020 Dec 2;:</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33268442</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2016 Mar;27(3):687-97</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26519085</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2020 Aug 3;3(8):e2018039</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32809033</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Med. 2022 Feb;22(1):125-135</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33891214</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Nephrol. 2020 Dec;16(12):747-764</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33060844</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2021 Jan;32(1):151-160</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2021 Jan;99(1):227-237</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33181156</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatol Int. 2020 Dec;40(12):2015-2021</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32945944</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2021 Jan;32(1):161-176</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33067383</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2021 Mar 1;4(3):e211095</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33688965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2020 May;97(5):829-838</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32247631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2020 Jun 25;5(8):1149-1160</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32775814</ArticleId></ArticleIdList></Reference><Reference><Citation>J Intern Med. 2021 Jul;290(1):166-178</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33452733</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Aug;584(7821):430-436</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2021 Oct;16(10):1601-1609</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34462285</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transplant. 2021 Aug;21(8):2913-2915</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33864722</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Clin Pharmacol. 2021 Apr;87(4):2111-2120</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33098713</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2021 Aug;78(2):314-317</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34019949</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2020 Sep;31(9):2145-2157</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32669322</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2021 Feb;27(2):264-269</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33311702</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2020 Jun;31(6):1145-1146</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32312797</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2021 Feb;77(2):190-203.e1</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32961244</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biomed Inform. 2019 Jul;95:103208</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Kidney J. 2020 Sep 02;13(4):550-563</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32897278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2021 Oct;80(10):1306-1311</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33762264</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2015 Oct;66(4):591-601</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25943717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 2020 Aug 7;:</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32769153</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Crit Care. 2019 Dec;25(6):573-579</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31689245</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2021 May 8;16(5):785-786</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33558255</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2021 Jun 1;325(21):2204-2206</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33950155</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"MEDLINE\" IndexingMethod=\"Automated\" Owner=\"NLM\"><PMID Version=\"1\">35373125</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">2641-7650</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>24</Day></PubDate></JournalIssue><Title>Kidney360</Title><ISOAbbreviation>Kidney360</ISOAbbreviation></Journal><ArticleTitle>A Propensity Score-Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease.</ArticleTitle><Pagination><MedlinePgn>269-278</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.34067/KID.0006152021</ELocationID><Abstract><AbstractText Label=\"Background\" NlmCategory=\"UNASSIGNED\">Remdesivir is not currently approved for patients with eGFR &lt;30 ml/min per 1.73 m<sup>2</sup>. We aimed to determine the safety of remdesivir in patients with kidney failure.</AbstractText><AbstractText Label=\"Methods\" NlmCategory=\"UNASSIGNED\">This study was a retrospective cohort study of patients with COVID-19 hospitalized between May 2020 and January 2021 with eGFR &lt;30 ml/min per 1.73 m<sup>2</sup> who received remdesivir and historical controls with COVID-19 hospitalized between March 1, 2020 and April 30, 2020 prior to the emergency use authorization of remdesivir within a large health care system. Patients were 1:1 matched by propensity scores accounting for factors associated with treatment assignment. Adverse events and hospital outcomes were recorded by manual chart review.</AbstractText><AbstractText Label=\"Results\" NlmCategory=\"UNASSIGNED\">The overall cohort included 34 hospitalized patients who initiated remdesivir within 72 hours of hospital admission with eGFR&lt;30 ml/min per 1.73 m<sup>2</sup> and 217 COVID-19 controls with eGFR &lt;30 ml/min per 1.73 m<sup>2</sup>. The propensity score-matched cohort included 31 remdesivir-treated patients and 31 nonremdesivir-treated controls. The mean age was 74.0 (SD=13.8) years, 57% were women, and 68% were white participants. A total of 26% had ESKD. Among patients who were not on dialysis prior to initiating remdesivir, one developed worsening kidney function (defined as ≥50% increase in creatinine or initiation of KRT) compared with three in the historical control group. There was no increased risk of cardiac arrythmia, cardiac arrest, altered mental status, or clinically significant anemia or liver function test abnormalities. There was a significantly increased risk of hyperglycemia, which may be partly explained by the increased use of dexamethasone in the remdesivir-treated population.</AbstractText><AbstractText Label=\"Conclusions\" NlmCategory=\"UNASSIGNED\">In this propensity score-matched study, remdesivir was well tolerated in patients with eGFR &lt;30 ml/min per 1.73 m<sup>2</sup>.</AbstractText><CopyrightInformation>Copyright © 2022 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Seethapathy</LastName><ForeName>Rituvanthikaa</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-5316-4610</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhao</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Long</LastName><ForeName>Joshua D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Strohbehn</LastName><ForeName>Ian A</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sise</LastName><ForeName>Meghan E</ForeName><Initials>ME</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-4327-9713</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D064888\">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Kidney360</MedlineTA><NlmUniqueID>101766381</NlmUniqueID><ISSNLinking>2641-7650</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000998\">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>3QKI37EEHE</RegistryNumber><NameOfSubstance UI=\"C000606551\">remdesivir</NameOfSubstance></Chemical><Chemical><RegistryNumber>415SHH325A</RegistryNumber><NameOfSubstance UI=\"D000249\">Adenosine Monophosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>OF5P57N2ZX</RegistryNumber><NameOfSubstance UI=\"D000409\">Alanine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type=\"Protocol\" UI=\"C000705127\">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000249\" MajorTopicYN=\"N\">Adenosine Monophosphate</DescriptorName><QualifierName UI=\"Q000031\" MajorTopicYN=\"N\">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000409\" MajorTopicYN=\"N\">Alanine</DescriptorName><QualifierName UI=\"Q000031\" MajorTopicYN=\"N\">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000998\" MajorTopicYN=\"N\">Antiviral Agents</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"Y\">COVID-19</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007668\" MajorTopicYN=\"N\">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D057216\" MajorTopicYN=\"N\">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006435\" MajorTopicYN=\"N\">Renal Dialysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D051437\" MajorTopicYN=\"Y\">Renal Insufficiency</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012189\" MajorTopicYN=\"N\">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086402\" MajorTopicYN=\"N\">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19</Keyword><Keyword MajorTopicYN=\"N\">SARS-CoV-2</Keyword><Keyword MajorTopicYN=\"N\">acute kidney injury</Keyword><Keyword MajorTopicYN=\"N\">antiviral</Keyword><Keyword MajorTopicYN=\"N\">chronic kidney disease</Keyword><Keyword MajorTopicYN=\"N\">dialysis</Keyword><Keyword MajorTopicYN=\"N\">propensity score</Keyword><Keyword MajorTopicYN=\"N\">remdesivir</Keyword></KeywordList><CoiStatement>M.E. Sise reports consultancy agreements with Bioporto; research funding from Abbvie, EMD-Serono, Gilead Sciences, and Merck; honoraria from the International Society of Hemodialysis for the Hemodialysis University Lecture; and scientific advisor or membership with Gilead Sciences as a scientific advisory board member and Travere Therapeutics as an scientific advisory board member. All remaining authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>09</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>4</Month><Day>4</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35373125</ArticleId><ArticleId IdType=\"doi\">10.34067/KID.0006152021</ArticleId><ArticleId IdType=\"pii\">K3602021000615</ArticleId><ArticleId IdType=\"pmc\">PMC8967642</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Microbiol Infect. 2021 Feb 27;:</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33647441</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 May 26;323(20):2052-2059</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2021 Jul;6(7):1987-1991</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33997535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2021 Mar;6(3):835-838</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33263094</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2010 Apr;55(4):622-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20338463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2021 Mar;6(3):586-593</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33354635</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2020 Jul;98(1):219-227</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32327202</ArticleId></ArticleIdList></Reference><Reference><Citation>Multivariate Behav Res. 2011 May;46(3):399-424</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2020 Dec 28;15(12):e0244131</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33370368</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 1996 Jul;22(7):707-10</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2020 Jul;31(7):1384-1386</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32513665</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2021 Feb 25;384(8):693-704</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0094321</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34137640</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Aug 6;383(6):590-592</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2006 Jun 15;163(12):1149-56</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16624967</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2021 Apr;109(4):1021-1024</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33340409</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2021 Jan;32(1):151-160</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2021 Jan;6(1):206-210</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33073066</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2020 Jun 25;5(8):1149-1160</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32775814</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2021 Apr;6(4):916-927</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33558853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2021 Sep;6(9):2305-2315</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34250317</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2020 Oct;31(10):2250-2252</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32900842</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Intern Med. 2021 Apr 1;181(4):471-478</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33351068</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 Dec 15;371:m4677</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33323357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2021 Jan;6(1):196-199</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33106779</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2021 Feb;77(2):190-203.e1</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32961244</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2012 Jan 23;172(2):153-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22271121</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Interv Aging. 2021 Jun 03;16:1037-1046</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34113086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Med. 2021 Sep-Oct;3(5):877-879</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34368666</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2020 Jul;98(1):209-218</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32416116</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Intern Med. 2013 Oct 28;173(19):1821-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24000014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int Rep. 2021 Oct;6(10):2565-2574</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34307971</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2021 May;99(5):1235-1236</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33647327</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2021 Dec 6;73(11):e3990-e3995</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33315065</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"MEDLINE\" IndexingMethod=\"Automated\" Owner=\"NLM\"><PMID Version=\"1\">35373088</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">2641-7650</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>2</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>24</Day></PubDate></JournalIssue><Title>Kidney360</Title><ISOAbbreviation>Kidney360</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Infection Risk Factors among Maintenance Hemodialysis Patients and Health Care Personnel In Outpatient Hemodialysis Centers.</ArticleTitle><Pagination><MedlinePgn>996-1001</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.34067/KID.0001282021</ELocationID><Abstract><AbstractText>Increased risk of SARS-CoV-2 infection was associated with community prevalence.Increased risk of SARS-CoV-2 infection was associated with exposure to infected family members and personal infection prevention measures.</AbstractText><CopyrightInformation>Copyright © 2021 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Gandra</LastName><ForeName>Sumanth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Reske</LastName><ForeName>Kimberly A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dang</LastName><ForeName>Na Le</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Farnsworth</LastName><ForeName>Christopher W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hock</LastName><ForeName>Karl G</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Miller</LastName><ForeName>Candace</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Olsen</LastName><ForeName>Margaret A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kwon</LastName><ForeName>Jennie H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Warren</LastName><ForeName>David K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fraser</LastName><ForeName>Victoria J</ForeName><Initials>VJ</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Kidney360</MedlineTA><NlmUniqueID>101766381</NlmUniqueID><ISSNLinking>2641-7650</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"Y\">COVID-19</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D003695\" MajorTopicYN=\"N\">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010045\" MajorTopicYN=\"N\">Outpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006435\" MajorTopicYN=\"N\">Renal Dialysis</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012307\" MajorTopicYN=\"N\">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086402\" MajorTopicYN=\"N\">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19</Keyword><Keyword MajorTopicYN=\"N\">ESRD</Keyword><Keyword MajorTopicYN=\"N\">SARS-CoV-2</Keyword><Keyword MajorTopicYN=\"N\">clinical nephrology</Keyword><Keyword MajorTopicYN=\"N\">delivery of health care</Keyword><Keyword MajorTopicYN=\"N\">health personnel</Keyword><Keyword MajorTopicYN=\"N\">hemodialysis</Keyword><Keyword MajorTopicYN=\"N\">outpatients</Keyword><Keyword MajorTopicYN=\"N\">risk factors</Keyword></KeywordList><CoiStatement>C.W. Farnsworth reports consultancy agreements with Roche Diagnostics and research funding from Abbott Diagnostics, Beckman Coulter, and Siemens Healthineers. T. Li reports consultancy agreements with ChemoCentryx, GlaxoSmithKline, and Reata Pharmaceuticals, Inc.; research funding from Aurinia Pharmaceuticals, Bristol-Myers Squibb, Human Genome Science, and Omeros Corporation; and scientific advisor or membership with the American Society of Nephrology (ASN) Education Committee (member), ASN Publications Committee (member), and GlaxoSmithKline (scientific advisor). M. A. Olsen received grant funding from Merck, Pfizer, and Sanofi Pasteur in the past 3 years and worked as a consultant to Pfizer not related to COVID-19. All remaining authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>02</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>04</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>4</Month><Day>4</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35373088</ArticleId><ArticleId IdType=\"doi\">10.34067/KID.0001282021</ArticleId><ArticleId IdType=\"pii\">K3602021000128</ArticleId><ArticleId IdType=\"pmc\">PMC8791360</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Soc Nephrol. 2020 Nov;31(11):2517-2521</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33077614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Med. 2020 Nov-Dec;2(6):716-723.e1</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33106788</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2020 Dec;98(6):1530-1539</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32810523</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2020 Aug;31(8):1815-1823</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32561681</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2021 May;77(5):748-756.e1</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33465417</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2020 Jul 23;58(8):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32381641</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Kidney J. 2020 Jul 13;13(4):542-549</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32885797</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2021 Mar;21(3):333-343</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33152271</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Oct 24;396(10259):1335-1344</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32987007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Jun 27;395(10242):1973-1987</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32497510</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"MEDLINE\" IndexingMethod=\"Automated\" Owner=\"NLM\"><PMID Version=\"1\">35373072</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">2641-7650</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>2</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>24</Day></PubDate></JournalIssue><Title>Kidney360</Title><ISOAbbreviation>Kidney360</ISOAbbreviation></Journal><ArticleTitle>Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients.</ArticleTitle><Pagination><MedlinePgn>924-936</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.34067/KID.0002172021</ELocationID><Abstract><AbstractText Label=\"Background\" NlmCategory=\"UNASSIGNED\">SARS-CoV-2 infection has, as of April 2021, affected &gt;133 million people worldwide, causing &gt;2.5 million deaths. Because the large majority of individuals infected with SARS-CoV-2 are asymptomatic, major concerns have been raised about possible long-term consequences of the infection.</AbstractText><AbstractText Label=\"Methods\" NlmCategory=\"UNASSIGNED\">Wedeveloped an antigen capture assay to detect SARS-CoV-2 spike protein in urine samples from patients with COVID-19whose diagnosis was confirmed by positive PCR results from nasopharyngeal swabs (NP-PCR+) forSARS-CoV-2. We used a collection of 233 urine samples from 132 participants from Yale New Haven Hospital and the Children's Hospital of Philadelphia that were obtained during the pandemic (106 NP-PCR+ and 26 NP-PCR-), and a collection of 20 urine samples from 20 individuals collected before the pandemic.</AbstractText><AbstractText Label=\"Results\" NlmCategory=\"UNASSIGNED\">Our analysis identified 23 out of 91 (25%) NP-PCR+ adult participants with SARS-CoV-2 spike S1 protein in urine (Ur-S+). Interestingly, although all NP-PCR+ children were Ur-S-, one child who was NP-PCR- was found to be positive for spike protein in their urine. Of the 23 adults who were Ur-S+, only one individual showed detectable viral RNA in urine. Our analysis further showed that 24% and 21% of adults who were NP-PCR+ had high levels of albumin and cystatin C, respectively, in their urine. Among individuals with albuminuria (&gt;0.3 mg/mg of creatinine), statistical correlation could be found between albumin and spike protein in urine.</AbstractText><AbstractText Label=\"Conclusions\" NlmCategory=\"UNASSIGNED\">Together, our data showed that one of four individuals infected with SARS-CoV-2 develop renal abnormalities, such as albuminuria. Awareness about the long-term effect of these findings is warranted.</AbstractText><CopyrightInformation>Copyright © 2021 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>George</LastName><ForeName>Santosh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pal</LastName><ForeName>Anasuya Chattopadhyay</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gagnon</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>L2 Diagnostics, LLC, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Timalsina</LastName><ForeName>Sushma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>L2 Diagnostics, LLC, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Singh</LastName><ForeName>Pallavi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vydyam</LastName><ForeName>Pratap</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Munshi</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chiu</LastName><ForeName>Joy E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Renard</LastName><ForeName>Isaline</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Harden</LastName><ForeName>Christina A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ott</LastName><ForeName>Isabel M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Watkins</LastName><ForeName>Anne E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vogels</LastName><ForeName>Chantal B F</ForeName><Initials>CBF</Initials><AffiliationInfo><Affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lu</LastName><ForeName>Peiwen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Immunology, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tokuyama</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Venkataraman</LastName><ForeName>Arvind</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Immunology, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Casanovas-Massana</LastName><ForeName>Arnau</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wyllie</LastName><ForeName>Anne L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rao</LastName><ForeName>Veena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Campbell</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Farhadian</LastName><ForeName>Shelli F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Grubaugh</LastName><ForeName>Nathan D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dela Cruz</LastName><ForeName>Charles S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ko</LastName><ForeName>Albert I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Berna Perez</LastName><ForeName>Amalia Z</ForeName><Initials>AZ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Akaho</LastName><ForeName>Elikplim H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Moledina</LastName><ForeName>Dennis G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Nephrology and Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Testani</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>John</LastName><ForeName>Audrey R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ledizet</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>L2 Diagnostics, LLC, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mamoun</LastName><ForeName>Choukri Ben</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><CollectiveName>and the Yale IMPACT Team</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Kidney360</MedlineTA><NlmUniqueID>101766381</NlmUniqueID><ISSNLinking>2641-7650</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D064370\">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C000657845\">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"Y\">COVID-19</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002648\" MajorTopicYN=\"N\">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D058873\" MajorTopicYN=\"N\">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086402\" MajorTopicYN=\"N\">SARS-CoV-2</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D064370\" MajorTopicYN=\"Y\">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19</Keyword><Keyword MajorTopicYN=\"N\">SARS-CoV-2</Keyword><Keyword MajorTopicYN=\"N\">acute kidney injury and ICU nephrology</Keyword><Keyword MajorTopicYN=\"N\">body fluids</Keyword><Keyword MajorTopicYN=\"N\">coronavirus</Keyword><Keyword MajorTopicYN=\"N\">enzyme-linked immunosorbent assay</Keyword><Keyword MajorTopicYN=\"N\">spike glycoprotein</Keyword><Keyword MajorTopicYN=\"N\">spike protein</Keyword><Keyword MajorTopicYN=\"N\">viral envelope proteins</Keyword></KeywordList><CoiStatement>A.I. Ko reportsreceiving research funding from Bristol Myers Squibb, Regeneron, Serimmune, and Tata Medical and Diagnostics; and having consultancy agreements with Tata Medical and Diagnostics. D.G. Moledina reports receiving honoraria from the British Medical Journal, National Kidney Foundation, and Remedy Health Media; serving as an editorial board member for Kidney360; receiving research funding from National Institute of Diabetes and Digestive and Kidney Diseases (grants K23DK117065, R01DK12681, UH3DK114866, and P30DK079310), outside the submitted work; and being a coinventor of the pending patent application “Methods and Systems for Diagnosis of Acute Interstitial Nephritis,” which is subject to an option for a license agreement with RenalytixAI Inc. A.R. John reports receiving research funding from the Burroughs Wellcome Fund and National Institutes of Health (NIH); being a scientific advisor for, or member of, Pluton Biosciences; and having patents and inventions involving antimalarials and malaria and SARS-CoV-2 biomarkers. V. Rao reports patents and inventions with Corvidia Therapeutics, and having consultancy agreements with Translational Catalyst. J. Testani reports receiving research funding from Abbott, Boehringer Ingelheim, Bristol Myers Squibb, 3ive Labs, Merck, NIH, Otsuka, Sanofi, Sequana Medical, The Foundry, and the US Food and Drug Administration; having consultancy agreements with, and receiving honoraria from, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cardionomic, FIRE1, Lexicon, Magenta Med, Merck, Novartis, Regeneron, Reprieve, Sanofi, Sequana Medical, Windtree Therapeutics, and W.L. Gore; having patents and inventions with Corvidia, Reprieve Inc., and Yale University; and having ownership interest in Reprive Inc. All remaining authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>03</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>04</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>4</Month><Day>4</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35373072</ArticleId><ArticleId IdType=\"doi\">10.34067/KID.0002172021</ArticleId><ArticleId IdType=\"pii\">K3602021000217</ArticleId><ArticleId IdType=\"pmc\">PMC8791366</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMC Nephrol. 2020 Aug 4;21(1):326</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32753052</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Nephrol. 2020;51(5):343-348</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32229732</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):470-473</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31986257</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Sep 24;383(13):1283-1286</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32857487</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2020 Apr;26(4):450-452</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32284615</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2020 Jul;31(7):1380-1383</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32366514</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2012 Jun;4(6):1011-33</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22816037</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 1999 May;33(5):1004-10</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10213663</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Sci. 2020 Dec;360(6):738-739</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32771219</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Oct 25;362(9393):1353-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14585636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2020 Jul;98(1):209-218</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32416116</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2012 Apr;4(4):557-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22590686</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):514-523</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31986261</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Mar;579(7798):270-273</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2016 Sep 27;20(1):299</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27670788</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2021 Jan;93(1):499-505</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32633815</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 2009 Mar;20(3):672-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19244578</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Apr 16;181(2):281-292.e6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2020 Aug;129:104500</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32585619</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2013 Feb;17(2):e143-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23270612</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 1984 Oct;77(4):699-702</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6486145</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Nephrol. 1992;12(1-2):49-54</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1415365</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Nephrol. 2012;2012:481520</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22685655</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Gastroenterol. 2019 Jul 28;25(28):3684-3703</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31391766</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Microbiol. 2020 Apr;5(4):562-569</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32094589</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephrol Dial Transplant. 1997;12 Suppl 2:6-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9269691</ArticleId></ArticleIdList></Reference><Reference><Citation>Interact Cardiovasc Thorac Surg. 2015 Mar;20(3):338-44</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25452556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Med. 2020 Apr;14(2):185-192</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Med Virol. 2021 May;31(3):e2176</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33022818</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Soc Exp Biol Med. 1969 Oct;132(1):27-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">5344846</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2020 Oct;99:328-333</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32497809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2005 Feb;67(2):698-705</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15673319</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35291567</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2667-193X</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>7</Volume><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Lancet Regional Health. Americas</Title><ISOAbbreviation>Lancet Reg Health Am</ISOAbbreviation></Journal><ArticleTitle>The effect of the COVID-19 pandemic on influenza-related hospitalization, intensive care admission and mortality in children in Canada: A population-based study.</ArticleTitle><Pagination><MedlinePgn>100132</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.lana.2021.100132</ELocationID><Abstract><AbstractText Label=\"Background\" NlmCategory=\"UNASSIGNED\">The COVID-19 pandemic resulted in unprecedented implementation of wide-ranging public health measures globally. During the pandemic, dramatic decreases in seasonal influenza virus detection have been reported worldwide. Information on the impact on paediatric influenza-related hospitalisations is limited. We describe influenza-related hospitalisation in children in Canada following the onset of the COVID-19 pandemic.</AbstractText><AbstractText Label=\"Methods\" NlmCategory=\"UNASSIGNED\">Data on influenza-related hospitalisations, intensive care unit (ICU) admissions and in-hospital deaths in children across Canada were obtained from the Canadian Immunisation Monitoring Program, ACTive (IMPACT). This national active surveillance initiative comprises 90% of all tertiary care paediatric beds in Canada. The study period included eleven influenza seasons, from the 2010/2011 season until the 2020/2021 season inclusive. Time series modelling was used to compare the observed to predicted influenza-related hospitalisations following the COVID-19 pandemic.</AbstractText><AbstractText Label=\"Results\" NlmCategory=\"UNASSIGNED\">Following the COVID-19 pandemic there was a significant decrease in paediatric influenza-related hospitalisations compared to predicted influenza-related hospitalisations for this time period (<i>p</i> &lt; 0•0001). No paediatric influenza-related hospitalisations, ICU admission or deaths were reported for the 2020/2021 influenza season.</AbstractText><AbstractText Label=\"Conclusions\" NlmCategory=\"UNASSIGNED\">We show complete absence of paediatric influenza infection-related hospitalisation in a Canadian National Surveillance Network during the 2020/2021 influenza season. This significant decrease is likely related in large part to non-pharmacological public health interventions implemented during the COVID-19 pandemic, although the potential role of viral interference is unknown.</AbstractText><AbstractText Label=\"Funding\" NlmCategory=\"UNASSIGNED\">The Canadian Immunisation Monitoring Program, Active (IMPACT) influenza surveillance is a national surveillance initiative managed by the Canadian Paediatric Society and conducted by the IMPACT network of paediatric investigators on behalf of the Public Health Agency of Canada's Centre for Immunisation and Respiratory Infectious Diseases.</AbstractText><CopyrightInformation>© 2021 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Groves</LastName><ForeName>Helen E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Hospital for Sick Children, Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Papenburg</LastName><ForeName>Jesse</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Divisions of Infectious Diseases and Medical Microbiology, Montreal Children's Hospital, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mehta</LastName><ForeName>Kayur</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bettinger</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Vaccine Evaluation Centre, BC Children's Hospital Research Institute, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sadarangani</LastName><ForeName>Manish</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vaccine Evaluation Centre, BC Children's Hospital Research Institute, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Halperin</LastName><ForeName>Scott A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Canadian Centre for Vaccinology, Halifax, NS, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalhousie University and the IWK Health Centre Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Morris</LastName><ForeName>Shaun K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Hospital for Sick Children, Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><CollectiveName>for members of the Canadian Immunization Monitoring Program Active (IMPACT)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Reg Health Am</MedlineTA><NlmUniqueID>9918232503006676</NlmUniqueID><ISSNLinking>2667-193X</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19</Keyword><Keyword MajorTopicYN=\"N\">Canada</Keyword><Keyword MajorTopicYN=\"N\">Influenza</Keyword><Keyword MajorTopicYN=\"N\">Paediatric</Keyword></KeywordList><CoiStatement>HEG: received personal fees from Abbvie unrelated to the submitted work; JP: Received grants from MedImmune and Sanofi Pasteur, and grants and personal fees from Seegene and AbbVie, all unrelated to the submitted work; MS received grants from GlaxoSmithKline, Seqius, Merck, Pfizer, VBI, Vaccines, Sanofi Pasteur, SYmvivo. All payments made to the institution. No personal payments received; SKM: Received an investigator-led grant and served on an advisory board with Pfizer, and personal fees from GlaxoSmithKline, all unrelated to the submitted work. KM, JAB, SAH: none declared.</CoiStatement><InvestigatorList><Investigator ValidYN=\"Y\"><LastName>Bancej</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Burton</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Embree</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Foo</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Bridger</LastName><ForeName>Natalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Morris</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Jadavji</LastName><ForeName>Taj</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Lebel</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Le Saux</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Top</LastName><ForeName>Karina A</ForeName><Initials>KA</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Tan</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>McConnell</LastName><ForeName>Athena</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Purewal</LastName><ForeName>Rupeena</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Déry</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Thibeault</LastName><ForeName>Roseline</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Vaudry</LastName><ForeName>Wendy</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Tran</LastName><ForeName>Dat</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Sauvé</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Moore</LastName><ForeName>Dorothy L</ForeName><Initials>DL</Initials></Investigator><Investigator ValidYN=\"Y\"><LastName>Lefebvre</LastName><ForeName>Marie-Astrid</ForeName><Initials>MA</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35291567</ArticleId><ArticleId IdType=\"doi\">10.1016/j.lana.2021.100132</ArticleId><ArticleId IdType=\"pii\">S2667-193X(21)00128-9</ArticleId><ArticleId IdType=\"pmc\">PMC8913102</ArticleId></ArticleIdList><?pmcsd ?><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30547-30553</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33168723</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Dis Now. 2021 Aug;51(5):418-423</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33991720</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Jul 28;324(4):335-336</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32525519</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2012 May 1;175(9):890-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22491083</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2021 May;15(3):407-412</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33128444</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2021 Nov 2;73(9):e2829-e2830</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33594407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2020 Oct 22;:</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34756193</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2020 Jun;25(25):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32613939</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2021 Apr;147(4):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33731367</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Data. 2020 Aug 27;7(1):286</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32855428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Microbe. 2020 Oct;1(6):e254-e262</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33103132</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Reg Health Am. 2021 Sep;1:100015</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34386788</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2021 Jul 23;70(29):1013-1019</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34292924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Child Adolesc Health. 2020 Nov;4(11):e42-e43</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32956616</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Rev Sociol. 2021 May;58(2):165-185</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34080780</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2016 Mar 24;13(3):e1001977</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27011229</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Biomed. 2020 Mar 19;91(1):157-160</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2021 Feb 12;12(1):1001</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33579926</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transplant. 2020 Dec;20(12):3681-3685</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33264506</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2019 Dec 16;:</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31843887</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2021 Jan 18;13(1):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33477649</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35261474</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">0899-8280</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>35</Volume><Issue>2</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Proceedings (Baylor University. Medical Center)</Title><ISOAbbreviation>Proc (Bayl Univ Med Cent)</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and the acceleration toward remote cancer care.</ArticleTitle><Pagination><MedlinePgn>259-260</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1080/08998280.2021.1984814</ELocationID><Abstract><AbstractText>The disruption caused by the COVID-19 pandemic has disproportionately affected cancer patients' access to care. As a result, many specialists in the United States, including oncologists, have adopted telemedicine-a transition largely made possible by reforms to insurer reimbursement schemes. Years after the COVID-19 crisis, there will continue to be a steady demand for remote outpatient visits, particularly in oncology. However, in a health system heavily influenced by reimbursements, strategies to optimize remote oncology care will not be embraced without appropriate incentives. Here we propose that restructuring financial incentives in three areas of cancer care-anticancer drug delivery, wearable health monitoring, and digital data-sharing tools-has the potential to improve patient outcomes, reduce overall costs, and expand clinical trial access for patients in underresourced areas. As with telemedicine, it is time for policymakers to recognize this need and adjust the incentives, both for routine care and for clinical trials, to make it possible.</AbstractText><CopyrightInformation>© 2021 The Author(s). Published with license by Taylor and Francis Group, LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wix</LastName><ForeName>Sophia N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Texas Christian University and University of North Texas Health Science Center School of Medicine, Fort Worth, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nieva</LastName><ForeName>Jorge J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Keck School of Medicine, USC/Norris Cancer Center, Los Angeles, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc (Bayl Univ Med Cent)</MedlineTA><NlmUniqueID>9302033</NlmUniqueID><ISSNLinking>0899-8280</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19</Keyword><Keyword MajorTopicYN=\"N\">oncology</Keyword><Keyword MajorTopicYN=\"N\">patient-reported outcomes</Keyword><Keyword MajorTopicYN=\"N\">remote care</Keyword><Keyword MajorTopicYN=\"N\">telemedicine</Keyword></KeywordList><CoiStatement>Dr. Nieva has patents related to the objective measurement of human performance and ownership interests in Cansera, Quantgene, and Epic Sciences. He has research funding from Merck and receives personal fees from Astra Zeneca, Western Oncolytics, Amgen, and Genentech. Ms. Wix has nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35261474</ArticleId><ArticleId IdType=\"doi\">10.1080/08998280.2021.1984814</ArticleId><ArticleId IdType=\"pii\">1984814</ArticleId><ArticleId IdType=\"pmc\">PMC8865276</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Curr Oncol. 2019 Feb;26(1):e70-e80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30853812</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2020 Jun 1;3(6):e2010651</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32478845</ArticleId></ArticleIdList></Reference><Reference><Citation>JCO Glob Oncol. 2020 Jul;6:1046-1051</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32639877</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35178046</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">1664-3224</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party.</ArticleTitle><Pagination><MedlinePgn>813957</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fimmu.2021.813957</ELocationID><Abstract><AbstractText>Multiple sclerosis (MS) is a central nervous system (CNS) disorder, which is mediated by an abnormal immune response coordinated by T and B cells resulting in areas of inflammation, demyelination, and axonal loss. Disease-modifying treatments (DMTs) are available to dampen the inflammatory aggression but are ineffective in many patients. Autologous hematopoietic stem cell transplantation (HSCT) has been used as treatment in patients with a highly active disease, achieving a long-term clinical remission in most. The rationale of the intervention is to eradicate inflammatory autoreactive cells with lympho-ablative regimens and restore immune tolerance. Immunological studies have demonstrated that autologous HSCT induces a renewal of TCR repertoires, resurgence of immune regulatory cells, and depletion of proinflammatory T cell subsets, suggesting a \"resetting\" of immunological memory. Although our understanding of the clinical and immunological effects of autologous HSCT has progressed, further work is required to characterize the mechanisms that underlie treatment efficacy. Considering that memory B cells are disease-promoting and stem-like T cells are multipotent progenitors involved in self-regeneration of central and effector memory cells, investigating the reconstitution of B cell compartment and stem and effector subsets of immunological memory following autologous HSCT could elucidate those mechanisms. Since all subjects need to be optimally protected from vaccine-preventable diseases (including COVID-19), there is a need to ensure that vaccination in subjects undergoing HSCT is effective and safe. Additionally, the study of vaccination in HSCT-treated subjects as a means of evaluating immune responses could further distinguish broad immunosuppression from immune resetting.</AbstractText><CopyrightInformation>Copyright © 2022 Cencioni, Genchi, Brittain, de Silva, Sharrack, Snowden, Alexander, Greco and Muraro.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Cencioni</LastName><ForeName>Maria Teresa</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Brain Sciences, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Genchi</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brittain</LastName><ForeName>Gavin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>South Yorkshire Regional Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals National Health Service (NHS) Foundation Trust, Sheffield, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Translational Neuroscience and Sheffield Neuroscience Biomedical Research Centre (BRC), Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>de Silva</LastName><ForeName>Thushan I</ForeName><Initials>TI</Initials><AffiliationInfo><Affiliation>South Yorkshire Regional Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals National Health Service (NHS) Foundation Trust, Sheffield, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sharrack</LastName><ForeName>Basil</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>South Yorkshire Regional Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals National Health Service (NHS) Foundation Trust, Sheffield, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Translational Neuroscience and Sheffield Neuroscience Biomedical Research Centre (BRC), Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Snowden</LastName><ForeName>John Andrew</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Haematology, Sheffield Teaching Hospitals National Health Service (NHS) Foundation Trust, Sheffield, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology and Metabolism, The University of Sheffield, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Alexander</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Rheuma-Forschungszentrum, ein Leibniz Institut, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Greco</LastName><ForeName>Raffaella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit of Haematology and Bone Marrow Transplantation, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Muraro</LastName><ForeName>Paolo A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Brain Sciences, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>16/126/26</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D056704\" MajorTopicYN=\"N\">Adaptive Immunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015551\" MajorTopicYN=\"Y\">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018380\" MajorTopicYN=\"Y\">Hematopoietic Stem Cell Transplantation</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007108\" MajorTopicYN=\"Y\">Immune Tolerance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007113\" MajorTopicYN=\"N\">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007156\" MajorTopicYN=\"Y\">Immunologic Memory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016131\" MajorTopicYN=\"N\">Lymphocyte Subsets</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"Y\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D020528\" MajorTopicYN=\"N\">Multiple Sclerosis, Chronic Progressive</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000601\" MajorTopicYN=\"Y\">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D020529\" MajorTopicYN=\"N\">Multiple Sclerosis, Relapsing-Remitting</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000601\" MajorTopicYN=\"Y\">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D010641\" MajorTopicYN=\"N\">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D014182\" MajorTopicYN=\"N\">Transplantation, Autologous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016896\" MajorTopicYN=\"N\">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"Y\">disease-modifying therapies (DMT)</Keyword><Keyword MajorTopicYN=\"Y\">hematopoietic stem cell (HSC) transplantation</Keyword><Keyword MajorTopicYN=\"Y\">immune reconstitution</Keyword><Keyword MajorTopicYN=\"Y\">immunological memory</Keyword><Keyword MajorTopicYN=\"Y\">vaccination</Keyword></KeywordList><CoiStatement>PM reports no conflict of interest. He discloses travel support and speaker honoraria from unrestricted educational activities organized by Novartis, Bayer HealthCare, Bayer Pharma, Biogen Idec, Merck Serono, and Sanofi Aventis. He also discloses consulting to Magenta Therapeutics and Jasper Therapeutics. JS declares honoraria for an advisory board from MEDAC, and as an IDMC member for a trial supported by Kiadis Pharma, all outside the submitted work. RG discloses honoraria for speaking from educational events supported by Biotest, Pfizer, and Magenta. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>2</Month><Day>18</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35178046</ArticleId><ArticleId IdType=\"doi\">10.3389/fimmu.2021.813957</ArticleId><ArticleId IdType=\"pmc\">PMC8846289</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JAMA Neurol. 2017 Aug 1;74(8):961-969</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28604916</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2008 Oct 25;372(9648):1502-17</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18970977</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Nov 29;491(7426):717-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23051753</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2010 Jun 29;8(6):e1000407</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20613858</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2017 Sep 12;89(11):1107-1116</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28835401</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2017 Feb;264(2):284-294</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27878443</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1190-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24532785</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2021 Jul;17(7):399-414</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34075251</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Neuroimmunol Neuroinflamm. 2020 Aug 14;7(6):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32801167</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2012 Jun;18(6):835-42</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22127896</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2021 Jan 20;:</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33472915</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2020 Oct;26(11):1351-1359</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31347948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Relat Disord. 2020 Oct;45:102439</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32769063</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Marrow Transplant. 1992 Jun;9(6):427-32</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1628126</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2009 Nov 20;31(5):702-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19932070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Marrow Transplant. 2021 Jul;56(7):1493-1508</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34031556</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2021 Oct 11;:</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34633525</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2012 Nov 24;380(9856):1819-28</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23122652</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2021 Aug 9;39(34):4778-4783</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34294480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Marrow Transplant. 2000 Mar;25(5):525-31</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10713630</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Marrow Transplant. 2020 Feb;55(2):283-306</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31558790</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2003 Oct 1;102(7):2364-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12763935</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2010 Oct 1;16(19):4695-701</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20688898</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Cell. 2021 Nov 8;39(11):1448-1449</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34717827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Marrow Transplant. 2012 Jul;47(7):946-51</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22056644</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2015 Apr 8;7(282):282ra48</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25855494</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2010 Aug;11(8):701-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20581831</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2021 Aug 31;97(9):e890-e901</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34253634</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2013 Sep;136(Pt 9):2888-903</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23864273</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2018 Sep;70(9):1459-1469</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29660266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Hematol. 2010 Mar;89(3):255-62</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19697028</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2021 Oct 7;138(14):1278-1281</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34339501</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2015 Sep 15;15(9):545-58</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26250739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2010 Apr;67(4):452-61</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20437580</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2004 Jun;10(3):284-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15222693</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neurol Scand. 2019 Nov;140(5):320-327</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31297793</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Oct 23;359(17):1838-41</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18946071</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2017 Feb 28;88(9):842-852</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28148635</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1116-21</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24554104</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2015 Apr 30;125(18):2865-74</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25736310</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Neurol. 2015 Feb;72(2):159-69</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25546364</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Feb 14;358(7):676-88</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18272891</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2009 Jul;15(7):808-13</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19525962</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Neurol. 2019 Apr;26(4):624-630</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30414315</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Jan 2;348(1):15-23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12510038</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2019 May;90(5):514-521</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30538138</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Cell Biol. 2018 May;96(5):507-525</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29437263</ArticleId></ArticleIdList></Reference><Reference><Citation>Haematologica. 2003 Mar;88(3):306-14</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12651270</ArticleId></ArticleIdList></Reference><Reference><Citation>Open Forum Infect Dis. 2018 Dec 26;6(1):ofy356</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30697576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2021 Jul;27(8):1198-1204</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33565902</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2014 Mar;124(3):1168-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24531550</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2009 Feb;15(2):229-37</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18805841</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2011 Mar 22;76(12):1066-70</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21422458</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2005 Mar 7;201(5):805-16</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15738052</ArticleId></ArticleIdList></Reference><Reference><Citation>EBioMedicine. 2021 Oct;72:103581</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34563483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2009 Mar;8(3):244-53</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19186105</ArticleId></ArticleIdList></Reference><Reference><Citation>BioDrugs. 2020 Jun;34(3):307-325</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32166703</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2021 Nov;27(11):1990-2001</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34522051</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2015 Oct;21(11):1423-30</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25583838</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Sci. 2005 Dec;26 Suppl 4:S200-3</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16388358</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Mar 2;354(9):899-910</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16510744</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2020 Apr;72(4):565-575</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31682074</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2009 Dec 15;183(12):7919-30</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19933869</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Neurol. 2021 Feb 22;12:647425</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33692748</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2011 Sep;134(Pt 9):2755-71</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21840891</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Marrow Transplant. 1997 Oct;20(8):631-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9383225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2018 Oct;24(12):1594-1604</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28870107</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2010 Sep;68(3):395-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20818793</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2009 Nov 20;31(5):834-44</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19879163</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2019 Oct 8;93(15):e1452-e1462</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31515290</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2018 Sep 20;175(1):85-100.e23</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30173916</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2017 Jul;13(7):391-405</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28621766</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2015 Feb 4;7(273):273ra13</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25653219</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2012 Nov 24;380(9856):1829-39</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23122650</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 May 17;366(20):1870-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22591293</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Neurol. 2020 Oct;27(10):2047-2055</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32418281</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2015 Mar 10;84(10):981-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25672923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Marrow Transplant. 2021 Jul;56(7):1509-1517</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33911200</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2011 Sep 18;17(10):1290-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21926977</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Mar 13;422(6928):164-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12634786</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2001 Jul 10;57(1):62-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11445629</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Neurol. 2017 Apr 1;74(4):459-469</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28241268</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2012 Jan 12;119(2):422-33</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22086415</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Marrow Transplant. 2012 Mar;47(3):337-41</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22395764</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2021 Nov 9;97(19):e1870-e1885</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34610987</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Haematol. 2021 Aug;8(8):e583-e592</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34224668</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2017 May 30;88(22):2072-2073</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28455384</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmun Rev. 2005 Nov;4(8):549-54</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16214094</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2019 Jan 14;37(3):452-457</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30554797</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Med. 2021 Jan 27;72:215-228</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33106103</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2012 Oct;135(Pt 10):2925-37</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22907116</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Blood Marrow Transplant. 2016 Aug;22(8):1493-1503</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27184625</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2015 Dec 9;7(317):317ra198</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26659572</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2017 Sep;189(3):268-278</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28498568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Neurol Disord. 2019 Sep 25;12:1756286419878323</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31598138</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Treat Options Neurol. 2021;23(7):19</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34025110</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Jan 19;376(3):221-234</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28002679</ArticleId></ArticleIdList></Reference><Reference><Citation>JCI Insight. 2020 Jan 30;5(2):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31877116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Marrow Transplant. 1998 Mar;21(6):537-41</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9543056</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 Aug 6;388(10044):576-85</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27291994</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2016 Feb;46(2):281-90</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26614103</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2018 May 07;9:834</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29867923</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2017 Sep 12;89(11):1117-1126</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28835403</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Immunopathol. 2019 May;41(3):283-297</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30891627</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Immunol. 2016 Aug;169:47-57</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27318116</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2020 May;21(5):578-587</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32231298</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2019 Jun;19(6):e200-e212</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30744963</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood Adv. 2017 Dec 20;1(27):2742-2755</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29296926</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2016 Dec 13;17(11):2811-2818</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27974195</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2019 Jan 15;321(2):165-174</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30644983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2013 Mar;73(3):341-54</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23463494</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Blood Marrow Transplant. 2000;6(5A):563-75</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11071262</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2011 Jan 27;117(4):1250-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21084709</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Blood Marrow Transplant. 2019 May;25(5):845-854</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30794930</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucosal Immunol. 2015 Mar;8(2):429-40</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25269706</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 1994 Jul 15;84(2):657-63</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8025290</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35118329</PMID><DateRevised><Year>2022</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">2522-6711</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>5</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Mediastinum (Hong Kong, China)</Title><ISOAbbreviation>Mediastinum</ISOAbbreviation></Journal><ArticleTitle>Systemic treatments for thymic tumors: a narrative review.</ArticleTitle><Pagination><MedlinePgn>24</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.21037/med-21-11</ELocationID><Abstract><AbstractText>Thymic epithelial tumours (TETs) are rare tumours originating from the thymus. Considering the rarity of this disease, the management of TETs is still challenging and difficult. In fact, all the worldwide clinical practice guidelines are based on data from retrospective analyses, prospective single arm trials or experts' opinions. The results of combined modality therapy (chemotherapy, surgery, radiotherapy) in thymic malignancies are reasonably good in less advanced cases whereas in case of advanced (unsuitable for surgery) or metastatic disease, a platinum-based chemotherapy is considered standard of care. Unfortunately, chemotherapy in the palliative setting has modest efficacy. Moreover, due to the lack of known oncogenic molecular alterations, no targeted therapy has been shown to be efficient for these tumours. In order to offer the best diagnostic and therapeutic tools, patients with TETs should be managed with a continuous and specific multidisciplinary expertise at any step of the disease, especially in the era of a novel coronavirus disease (COVID-19). Current evidences show that cancer patients might have more severe symptoms and poorer outcomes from COVID-19 infection than general population. With the exception of the patients carrying a Good's syndrome, there is no evidence that patients with TETs present a higher risk of infection compared with other cancer patients and their management should be the same. The aim of this review is to summarize the existing literature about systemic treatments for TETs in all clinical setting (local and locally advanced/metastatic disease) exploring how these therapeutic strategies have been managed in the COVID-19 era.</AbstractText><CopyrightInformation>2021 Mediastinum. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Zucali</LastName><ForeName>Paolo Andrea</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>De Vincenzo</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Perrino</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Digiacomo</LastName><ForeName>Nunzio</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cordua</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>D'Antonio</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Borea</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Santoro</LastName><ForeName>Armando</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Mediastinum</MedlineTA><NlmUniqueID>101731833</NlmUniqueID><ISSNLinking>2522-6711</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19</Keyword><Keyword MajorTopicYN=\"N\">Thymic epithelial tumours (TETs)</Keyword><Keyword MajorTopicYN=\"N\">systemic therapy</Keyword></KeywordList><CoiStatement>Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/med-21-11). The series “Changes in management of mediastinal tumours following the surge of COVID-19 pandemic” was commissioned by the editorial office without any funding or sponsorship. PAZ reports outside the submitted work personal fees for advisory role, speaker engagements and travel and accommodation expenses from Merck Sharp &amp; Dohme (MSD), Astellas, Janssen, Sanofi, Ipsen, Pfizer, Novartis, Bristol Meyer Squibb, Amgen, Astrazeneca, Roche, and Bayer. AS reports outside the submitted work personal fees for consultant or advisory role for SArqule, Sanofi, BMS, Servier, Gilead, Pfizer, Eisai, Bayer, Merck Sharp &amp; Dohme (MSD). The authors have no other conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>06</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35118329</ArticleId><ArticleId IdType=\"doi\">10.21037/med-21-11</ArticleId><ArticleId IdType=\"pii\">med-05-24</ArticleId><ArticleId IdType=\"pmc\">PMC8794302</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Thorac Cardiovasc Surg. 2015 Jan;149(1):95-100, 101.e1-2</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25524678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 1993 May;4(5):429-31</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8353078</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Thorac Cardiovasc Surg. 2005 Spring;17(1):27-31</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16104358</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2019 Aug 20;37(24):2162-2170</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29906252</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer. 2013 Apr;80(1):75-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23313005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer. 2004 Jun;44(3):369-79</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15140551</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2018 Nov;13(11):1762-1770</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30138763</ArticleId></ArticleIdList></Reference><Reference><Citation>Interact Cardiovasc Thorac Surg. 2012 Aug;15(2):273-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22552797</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2014 Jan;147(1):36-44, 46.e1</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24139613</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorac Cancer. 2014 Mar;5(2):169-73</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26766995</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 1994 Jul 15;74(2):606-17</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8033040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2015 Feb;99(2):462-70</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25534526</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2018 Dec;13(12):1940-1948</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30121390</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2009 Aug;9(8):493-504</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19628174</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Oncol. 2005 Feb;28(1):5-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15685027</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Arthritis Rheum. 1998 Oct;28(2):73-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9806367</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2014 Feb;15(2):191-200</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24439931</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2002 Jul 15;95(2):420-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12124843</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncologist. 2020 Apr;25(4):e668-e674</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31771990</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorac Surg Clin. 2011 Feb;21(1):33-46, vi</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21070985</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 2002 Sep;124(3):493-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12202865</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 1991 Jul 1;68(1):30-3</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2049749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2003 Nov;76(5):1635-41; discussion 1641-2</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14602300</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2013 Jul;8(7):959-66</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23722169</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2011 Dec;6(12):2130-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21892103</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Oncol. 2002 Jun;25(3):266-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12040285</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer. 2004 Apr;44(1):69-77</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15013585</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2011 Jul;6(7 Suppl 3):S1698-704</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21847050</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2014 Nov 1;20(21):5392-402</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25189481</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2015 Feb;26(2):363-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25403584</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 2010 Jul 13;103(2):196-200</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20571495</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S88-96</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25396317</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):651-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7790251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2003 Sep;76(3):878-84; discussion 884-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12963221</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2020 May;21(5):619-621</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32220659</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2009 Oct;4(10):1270-3</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20197733</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2018 Feb 1;36(4):342-349</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29240542</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1974 Aug;134(2):374-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">4602050</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2018 Mar;19(3):347-355</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29395863</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cancer Res. 2009 Nov 15;15(22):6790-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19861435</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Oncol. 2020 Jul 1;6(7):1108-1110</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32211820</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 1991 Aug 15;68(4):706-13</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1855170</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Treat Rev. 2018 Dec;71:76-87</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30366202</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Dis. 2013 Apr;5(2):161-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23585943</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 2010 Jun 29;103(1):6-11</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20551960</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer. 2016 Jul;97:99-104</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27237035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer. 2008 Apr;60(1):4-13</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18343528</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2020 Jun;21(6):843-850</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32502444</ArticleId></ArticleIdList></Reference><Reference><Citation>ESMO Open. 2020 Jun;5(Suppl 3):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32581069</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2011 May 20;29(15):2060-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21502559</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2011 Jul;6(7 Suppl 3):S1710-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21847052</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S313-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20859125</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer. 2016 Sep;99:111-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27565923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Anat. 2008;190(3):238-45</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18356031</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2001 Jun 1;91(11):2010-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11391579</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S73-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25396315</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Oncol. 2017 Mar;29(2):112-117</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28027106</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2004 Jan 15;22(2):293-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14722038</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S65-72</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25396314</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2011 May 20;29(15):2052-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21502553</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Chemother Pharmacol. 2012 Feb;69(2):309-15</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21710245</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2010 Jun;5(6):893-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20521356</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S260-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20859116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2015 Sep;26 Suppl 5:v40-55</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26314779</ArticleId></ArticleIdList></Reference><Reference><Citation>Mod Pathol. 2017 Jun;30(6):826-833</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28281549</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2015 Mar;10(3):500-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25402569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2008 Feb;85(2):385-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18222230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2002 Oct;74(4):1033-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12400741</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2007 Jan;2(1):73-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17410014</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2020 Mar;21(3):335-337</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2005 Jun;79(6):1840-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15919267</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2004 Apr 15;22(8):1501-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15084623</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunother Cancer. 2019 Oct 21;7(1):269</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31639039</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S81-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25396316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2010 Jun;21(6):1168-1172</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19880439</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathol Int. 1994 May;44(5):359-67</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8044305</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 1999 Sep;17(9):2737-44</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10561348</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2002 Mar 1;94(5):1414-20</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11920496</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 1996 Mar;14(3):814-20</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8622029</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Rev Oncol Hematol. 2016 Mar;99:332-50</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26818050</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2020 Apr;109(4):1095-1103</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31877285</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 1988 Jun;95(6):1041-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3374155</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 1996 Feb;61(2):521-4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8572759</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S131-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25396310</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 1996 Aug;112(2):376-84</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8751506</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorac Cancer. 2020 Oct;11(10):2924-2931</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32869525</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Immunol. 2011 May;8(3):199-202</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21317916</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir Rev. 2013 Mar 1;22(127):75-87</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23457169</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 2019 May;113:78-86</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30991261</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2015 Feb;16(2):177-86</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25592632</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncol Rep. 2008 Jun;19(6):1525-31</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18497960</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2003 Sep 1;98(5):926-31</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12942558</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):654-64</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15183468</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 1981 Dec 1;48(11):2485-92</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7296496</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 1999 Nov;81(5):841-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10555755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Thorac Surg. 2003 Dec;76(6):1866-72; discussion 1872</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14667602</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Cardiovasc Surg. 1993 Sep;106(3):543-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8361199</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2009 Jun;4(6):773-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19461405</ArticleId></ArticleIdList></Reference><Reference><Citation>Anticancer Res. 2007 Jul-Aug;27(4C):3005-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17695487</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer. 2015 May;88(2):154-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25799277</ArticleId></ArticleIdList></Reference><Reference><Citation>ESMO Open. 2020 Apr;5(2):e000765</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32245904</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 1994 Jun;12(6):1164-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8201378</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 1997 Sep;15(9):3093-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9294472</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2010 Jan;37(1):13-25</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19615917</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cardiothorac Surg. 2014 Sep;46(3):361-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24482389</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Today. 2001;31(11):1038-40</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11766079</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cancer Res Clin Oncol. 2015 Feb;141(2):323-31</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25146529</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35118328</PMID><DateRevised><Year>2022</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">2522-6711</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>5</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Mediastinum (Hong Kong, China)</Title><ISOAbbreviation>Mediastinum</ISOAbbreviation></Journal><ArticleTitle>Targeted therapies for unresectable stage III non-small cell lung cancer.</ArticleTitle><Pagination><MedlinePgn>22</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.21037/med-21-8</ELocationID><Abstract><AbstractText>Until recently, the standard treatment in unresectable stage III non-small cell lung cancer was concurrent chemoradiotherapy, but often with dismal outcome. The introduction of consolidation treatment with immune checkpoint inhibitors has shifted the treatment landscape and prognosis of these patients. However, patients whose tumors harbors an epidermal growth factor receptor (EGFR) mutation derived less benefit, with an increased risk of immune-related adverse events. Moreover, current data suggested that patients with oncogenic addicted tumors, mainly <i>EGFR</i>-positive tumors, and also anaplastic lymphoma kinase (<i>ALK</i>)-positive have poorer progression free survival after chemoradiotherapy. Indeed, these tumors have also inferior distant control compared with those who have wild-type disease, especially in the central nervous system, highlighting the need for assessing the role of targeted therapies in this patient population. It is speculated that outcome could probably increase with a consolidation treatment strategy including an EGFR tyrosine kinase inhibitor. However, a personalized treatment approach is not considered standard of care in this setting due to lack of robust evidence, as the majority of trials were performed in unselected patients, number of patients is limited and the majority of these studies were underpowered. In this review we summarize the role of tyrosine kinase inhibitors in unresectable stage III NSCLC, specifically focusing on <i>EGFR</i>-mutant tumors.</AbstractText><CopyrightInformation>2021 Mediastinum. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Remon</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Centro Integral Oncológico Clara Campal (HM-CIOCC), Hospital HM Delfos, HM Hospitales, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hendriks</LastName><ForeName>Lizza E L</ForeName><Initials>LEL</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Maastricht University Medical Centre, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Mediastinum</MedlineTA><NlmUniqueID>101731833</NlmUniqueID><ISSNLinking>2522-6711</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">EGFR-mutant</Keyword><Keyword MajorTopicYN=\"N\">chemo-radiotherapy</Keyword><Keyword MajorTopicYN=\"N\">concurrent</Keyword><Keyword MajorTopicYN=\"N\">non-small cell lung cancer (NSCLC)</Keyword><Keyword MajorTopicYN=\"N\">sequential</Keyword></KeywordList><CoiStatement>Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/med-21-8). The series “Changes in management of mediastinal tumours following the surge of COVID-19 pandemic” was commissioned by the editorial office without any funding or sponsorship. JR reports personal fees and other from MSD, other from BOEHRINGER, other from PFIZER, personal fees and other from OSE IMMUNOTHERAPEUTICS, other from BMS, other from ASTRAZENECA, other from ROCHE, outside the submitted work. LELH reports other from boehringer ingelheim, other from BMS, other from Roche Genentech, other from BMS, grants from Roche Genentech, grants from Boehringer Ingelheim, other from AstraZeneca, personal fees from Quadia, grants from Astra Zeneca, other from Eli Lilly, other from Roche Genentech, other from Pfizer, other from MSD, other from Takeda, non-financial support from AstraZeneca, non-financial support from Novartis, non-financial support from BMS, non-financial support from MSD /Merck, non-financial support from GSK, non-financial support from Takeda, non-financial support from Blueprint Medicines, non-financial support from Roche Genentech, outside the submitted work. The authors have no other conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>01</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>05</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35118328</ArticleId><ArticleId IdType=\"doi\">10.21037/med-21-8</ArticleId><ArticleId IdType=\"pii\">med-05-22</ArticleId><ArticleId IdType=\"pmc\">PMC8794453</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):317-24</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25968826</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res Treat. 2017 Oct;49(4):981-989</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28111430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2020 Aug;31(8):1056-1064</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32418886</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2020 Jun;31(6):798-806</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32209338</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorac Cancer. 2018 Nov;9(11):1398-1405</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30152040</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2015 Dec;10(12):1720-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26743855</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Transl Radiat Oncol. 2019 Jun 27;18:32-38</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31341973</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2018 Nov 22;379(21):2027-2039</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30280657</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Lung Cancer. 2017 May;18(3):e169-e178</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28131636</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2010 May 1;28(13):2181-90</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20351327</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2010 Sep;5(9):1382-90</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20686428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2014 Jan;15(1):59-68</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24331154</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2008 May 20;26(15):2450-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18378568</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Lung Cancer. 2016 Jan;17(1):75-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26387039</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2020 Feb;15(2):248-257</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31778797</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Nov 16;377(20):1919-1929</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28885881</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Oncol. 2017 Aug 1;3(8):1120-1129</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27978552</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2019 Aug 1;30(8):1321-1328</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31125062</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Aug 13;383(7):640-649</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32786189</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncol Lett. 2017 Jul;14(1):885-890</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28693247</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2016 Mar 20;34(9):953-62</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26811519</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2012 Nov 10;30(32):3953-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23045594</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2021 Feb;16(2):278-288</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33188912</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Mol Sci. 2019 Jul 25;20(15):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31349558</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2021 May;16(5):868-872</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33539970</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cancer. 2019 Sep;19(9):495-509</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31406302</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 Apr 2;387(10026):1415-1426</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26777916</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2015 Jan;10(1):143-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25384173</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Oncol. 2014 Apr;37(2):144-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23211219</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Jan 2;382(1):41-50</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31751012</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Anticancer Ther. 2019 Jun;19(6):533-539</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31104529</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Lung Cancer. 2019 Jan;20(1):e25-e27</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30266586</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Sci. 2009 Aug;100(8):1520-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19432883</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2020 Nov 15;80(22):5121-5133</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32907839</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2020 Oct 1;126(19):4353-4361</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32697352</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30285222</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2012 Sep;23(9):2253-2258</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22357446</ArticleId></ArticleIdList></Reference><Reference><Citation>Future Oncol. 2019 Sep;15(25):2943-2953</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31037966</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2021 Jun;16(6):1030-1041</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33588109</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncotarget. 2017 Apr 11;8(15):25189-25199</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28445990</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thorac Oncol. 2010 Jan;5(1):29-33</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19952801</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2019 Dec;20(12):1670-1680</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31601496</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Oct 29;383(18):1711-1723</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32955177</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2020 Mar 1;38(7):706-714</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31841363</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35111162</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">1664-3224</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications.</ArticleTitle><Pagination><MedlinePgn>796482</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fimmu.2021.796482</ELocationID><Abstract><AbstractText Label=\"Background\">Vaccination campaign to contrast the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has raised the issue of vaccine immunogenicity in special populations such as people with multiple sclerosis (PwMS) on highly effective disease modifying treatments (DMTs). While humoral responses to SARS-CoV-2 mRNA vaccines have been well characterized in the general population and in PwMS, very little is known about cell-mediated responses in conferring protection from SARS-CoV-2 infection and severe coronavirus disease-2019 (COVID-19).</AbstractText><AbstractText Label=\"Methods\">PwMS on ocrelizumab, fingolimod or natalizumab, vaccinated with two doses of mRNABNT162b2 (Comirnaty<sup>®</sup>) vaccine were enrolled. Anti-Spike (S) and anti-Nucleoprotein (N) antibody titers, IFN-gamma production upon S and N peptide libraries stimulation, peripheral blood lymphocyte absolute counts were assessed after at least 1 month and within 4 months from vaccine second dose administration. A group of age and sex matched healthy donors (HD) were included as reference group. Statistical analysis was performed using GraphPad Prism 8.2.1.</AbstractText><AbstractText Label=\"Results\">Thirty PwMS and 9 HDs were enrolled. All the patients were negative for anti-N antibody detection, nor reported previous symptoms of COVID-19. Peripheral blood lymphocyte counts were assessed in PwMS showing: (i) reduction of circulating B-lymphocytes in PwMS on ocrelizumab; (ii) reduction of peripheral blood B- and T-lymphocyte absolute counts in PwMS on fingolimod and (iii) normal B- and T-lymphocyte absolute counts with an increase in circulating CD16+CD56+ NK-cells in PwMS on natalizumab. Three patterns of immunological responses were identified in PwMS. In patients on ocrelizumab, anti-S antibody were lacking or reduced, while T-cell responses were normal. In patients on fingolimod both anti-S titers and T-cell mediated responses were impaired. In patients on natalizumab both anti-S titers and T-cell responses were present and comparable to those observed in HD.</AbstractText><AbstractText Label=\"Conclusions\">The evaluation of T-cell responses, anti-S titers and peripheral blood lymphocyte absolute count in PwMS on DMTs can help to better characterize the immunological response after SARS-CoV-2 vaccination. The evaluation of T-cell responses in longitudinal cohorts of PwMS will help to clarify their protective role in preventing SARS-CoV-2 infection and severe COVID-19. The correlation between DMT treatment and immunological responses to SARS-CoV-2 vaccines could help to better evaluate vaccination strategies in PwMS.</AbstractText><CopyrightInformation>Copyright © 2022 Iannetta, Landi, Cola, Campogiani, Malagnino, Teti, Coppola, Di Lorenzo, Fraboni, Buccisano, Grelli, Mozzani, Zingaropoli, Ciardi, Nisini, Bernardini, Andreoni, Marfia and Sarmati.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Iannetta</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Landi</LastName><ForeName>Doriana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cola</LastName><ForeName>Gaia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Campogiani</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Malagnino</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Teti</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Coppola</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Di Lorenzo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fraboni</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Buccisano</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Grelli</LastName><ForeName>Sandro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mozzani</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zingaropoli</LastName><ForeName>Maria Antonella</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ciardi</LastName><ForeName>Maria Rosa</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nisini</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bernardini</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Andreoni</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Marfia</LastName><ForeName>Girolama Alessandra</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Neurology, IRCCS Istituto Neurologico Mediterraneo NEUROMED, Pozzilli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sarmati</LastName><ForeName>Loredana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016430\">Clinical Trial</PublicationType><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>N38TVC63NU</RegistryNumber><NameOfSubstance UI=\"D000090982\">BNT162 Vaccine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001402\" MajorTopicYN=\"N\">B-Lymphocytes</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"Y\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000090982\" MajorTopicYN=\"N\">BNT162 Vaccine</DescriptorName><QualifierName UI=\"Q000008\" MajorTopicYN=\"Y\">administration &amp; dosage</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"Y\">COVID-19</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000517\" MajorTopicYN=\"N\">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009103\" MajorTopicYN=\"N\">Multiple Sclerosis</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"Y\">immunology</QualifierName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086402\" MajorTopicYN=\"N\">SARS-CoV-2</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"Y\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D013601\" MajorTopicYN=\"N\">T-Lymphocytes</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"Y\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D014611\" MajorTopicYN=\"Y\">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"Y\">CD20</Keyword><Keyword MajorTopicYN=\"Y\">COVID</Keyword><Keyword MajorTopicYN=\"Y\">IGRA</Keyword><Keyword MajorTopicYN=\"Y\">T-lymphocyte</Keyword><Keyword MajorTopicYN=\"Y\">fingolimod</Keyword><Keyword MajorTopicYN=\"Y\">natalizumab</Keyword><Keyword MajorTopicYN=\"Y\">ocrelizumab</Keyword><Keyword MajorTopicYN=\"Y\">peptides</Keyword></KeywordList><CoiStatement>MI received honoraria for lectures from Biogen Italia, AIM Educational, MICOM srl. DL received travel funding from Biogen, Merk-Serono, Sanofi-Genzyme, Teva, speaking or consultation fees from Sanofi-Genzyme, Merk-Serono, Teva, Biogen, Novartis, Roche. LC received honoraria for lectures from MICOM srl. VM received honoraria for lectures from Janssen-Cilag. ET received honoraria for lectures from Gilead, AbbVie and MSD, and research grants from Gilead, outside the submitted work. FB received honoraria for lectures from Novartis. MA reports honoraria for lectures and research grants from Merk, Gilead, Abbvie, Angelini SpA, outside the submitted work. GM is an Advisory Board member of Biogen Idec, Genzyme, Merck-Serono, Novartis, Teva and received honoraria for speaking or consultation fees from Almirall, Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi-Genzyme, Roche, Mylan, Teva. LS reports honoraria for lectures and research grants from Merk, Gilead, Abbvie, Angelini SpA, outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>2</Month><Day>3</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35111162</ArticleId><ArticleId IdType=\"doi\">10.3389/fimmu.2021.796482</ArticleId><ArticleId IdType=\"pmc\">PMC8801814</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neurol Neuroimmunol Neuroinflamm. 2021 Jul 28;8(5):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34321333</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Relat Disord. 2021 Oct;55:103157</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34418737</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Relat Disord. 2020 Oct;45:102442</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32777745</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Sci. 2014 Jun 15;341(1-2):22-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24731783</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2018 Nov 29;36(50):7632-7640</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30392766</ArticleId></ArticleIdList></Reference><Reference><Citation>Respir Res. 2021 Jun 1;22(1):165</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34074288</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Res. 2012 Sep;34(7):730-3</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22709910</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2021 Jul 27;16(7):e0255316</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34314457</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2011 Feb;69(2):408-13</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21387383</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2021 Jul;595(7868):572-577</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34044428</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Neurol Disord. 2021 Aug 13;14:17562864211038111</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34413902</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2021 Nov 2;73(9):e3130-e3132</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33035306</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2021 Dec 3;374(6572):abm0829</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34648302</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2015 Mar 3;84(9):872-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25636714</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2021 Jul;27(7):1280-1289</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34017137</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Neurol Disord. 2021 May 29;14:17562864211020082</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34104221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Neurol Disord. 2021 Apr 22;14:17562864211012835</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34035836</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34240579</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Nov 12;183(4):996-1012.e19</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33010815</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2021 Sep 14;54(9):2133-2142.e3</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34453880</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunol Res. 2021 Dec;69(6):576-583</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34417958</ArticleId></ArticleIdList></Reference><Reference><Citation>EBioMedicine. 2021 Oct;72:103581</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34563483</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2021 Nov;27(11):1990-2001</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34522051</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2021 Feb;590(7847):630-634</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33276369</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Neurol. 2021 Dec 1;78(12):1510-1514</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34554197</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2021 Apr 6;325(13):1318-1320</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33635317</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2020 Aug;20(8):457-458</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32636479</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Adv Neurol Disord. 2021 May 31;14:17562864211019567</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34104219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2021 Jun 17;11(1):12762</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34140530</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2020 Oct 6;95(14):e1999-e2008</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32727835</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuroimmunol. 2021 Oct 15;359:577696</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34418815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 2021 Apr;89(4):780-789</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33480077</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35095257</PMID><DateRevised><Year>2022</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Print\">1083-6160</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>25</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>17</Day></PubDate></JournalIssue><Title>Organic process research &amp; development</Title><ISOAbbreviation>Org Process Res Dev</ISOAbbreviation></Journal><ArticleTitle>Development of a Robust Manufacturing Route for Molnupiravir, an Antiviral for the Treatment of COVID-19.</ArticleTitle><Pagination><MedlinePgn>2806-2815</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1021/acs.oprd.1c00400</ELocationID><Abstract><AbstractText>Herein is described the development of a large-scale manufacturing process for molnupiravir, an orally dosed antiviral that was recently demonstrated to be efficacious for the treatment of patients with COVID-19. The yield, robustness, and efficiency of each of the five steps were improved, ultimately culminating in a 1.6-fold improvement in overall yield and a dramatic increase in the overall throughput compared to the baseline process.</AbstractText><CopyrightInformation>© 2021 American Chemical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Fier</LastName><ForeName>Patrick S</ForeName><Initials>PS</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-6102-815X</Identifier><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xu</LastName><ForeName>Yingju</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Poirier</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brito</LastName><ForeName>Gilmar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zheng</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bade</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-5384-9687</Identifier><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sirota</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-6205-0295</Identifier><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stone</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tan</LastName><ForeName>Lushi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Humphrey</LastName><ForeName>Guy R</ForeName><Initials>GR</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0001-8634-1567</Identifier><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chang</LastName><ForeName>Darryl</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bothe</LastName><ForeName>Jameson</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Yongqian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bernardoni</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Castro</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zompa</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-2401-7846</Identifier><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Taylor</LastName><ForeName>Jerry</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sirk</LastName><ForeName>Kevin M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Diaz-Santana</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Diribe</LastName><ForeName>Ike</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Emerson</LastName><ForeName>Khateeta M</ForeName><Initials>KM</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0001-9226-2152</Identifier><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Krishnamurthi</LastName><ForeName>Bharath</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhao</LastName><ForeName>Ralph</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-2205-8919</Identifier><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ward</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xiao</LastName><ForeName>Chengqian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>WuXi AppTec Co., Ltd., WaiGaoQiao Free Trade Zone, Shanghai 200131, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ouyand</LastName><ForeName>Honggui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>WuXi AppTec Co., Ltd., WaiGaoQiao Free Trade Zone, Shanghai 200131, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhan</LastName><ForeName>Jianfeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>WuXi AppTec Co., Ltd., WaiGaoQiao Free Trade Zone, Shanghai 200131, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Morris</LastName><ForeName>William J</ForeName><Initials>WJ</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-4322-4509</Identifier><AffiliationInfo><Affiliation>Department of Process Research and Development, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Org Process Res Dev</MedlineTA><NlmUniqueID>9890443</NlmUniqueID><ISSNLinking>1083-6160</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>1</Month><Day>31</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35095257</ArticleId><ArticleId IdType=\"doi\">10.1021/acs.oprd.1c00400</ArticleId><ArticleId IdType=\"pmc\">PMC8790826</ArticleId></ArticleIdList><?pmcsd ?><ReferenceList><Reference><Citation>Nat Struct Mol Biol. 2021 Sep;28(9):740-746</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34381216</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2020 Apr 29;12(541):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32253226</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2021 Mar;591(7850):451-457</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33561864</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Microbiol. 2021 Jan;6(1):11-18</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33273742</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Chem. 1988 Jul;31(7):1475-9</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2455053</ArticleId></ArticleIdList></Reference><Reference><Citation>Chem Commun (Camb). 2020 Nov 11;56(87):13363-13364</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33030468</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35046939</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">1664-3224</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks.</ArticleTitle><Pagination><MedlinePgn>775420</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fimmu.2021.775420</ELocationID><Abstract><AbstractText Label=\"Background\">As part of the public health outbreak investigations, serological surveys were carried out following two COVID-19 outbreaks in April 2020 and October 2020 in one long term care facility (LTCF) in British Columbia, Canada. This study describes the serostatus of the LTCF residents and monitors changes in their humoral response to SARS-CoV-2 and other human coronaviruses (HCoV) over seven months.</AbstractText><AbstractText Label=\"Methods\">A total of 132 serum samples were collected from all 106 consenting residents (aged 54-102) post-first outbreak (N=87) and post-second outbreak (N=45) in one LTCF; 26/106 participants provided their serum following both COVID-19 outbreaks, permitting longitudinal comparisons between surveys. Health-Canada approved commercial serologic tests and a pan-coronavirus multiplexed immunoassay were used to evaluate antibody levels against the spike protein, nucleocapsid, and receptor binding domain (RBD) of SARS-CoV-2, as well as the spike proteins of HCoV-229E, HCoV-HKU1, HCoV-NL63, and HCoV-OC43. Statistical analyses were performed to describe the humoral response to SARS-CoV-2 among residents longitudinally.</AbstractText><AbstractText Label=\"Findings\">Survey findings demonstrated that among the 26 individuals that participated in both surveys, all 10 individuals seropositive after the first outbreak continued to be seropositive following the second outbreak, with no reinfections identified among them. SARS-CoV-2 attack rate in the second outbreak was lower (28.6%) than in the first outbreak (40.2%), though not statistically significant (P&gt;0.05). Gradual waning of anti-nucleocapsid antibodies to SARS-CoV-2 was observed on commercial (median Δ=-3.7, P=0.0098) and multiplexed immunoassay (median Δ=-169579, P=0.014) platforms; however, anti-spike and anti-receptor binding domain (RBD) antibodies did not exhibit a statistically significant decline over 7 months. Elevated antibody levels for beta-HCoVs OC43 (P&lt;0.0001) and HKU1 (P=0.0027) were observed among individuals seropositive for SARS-CoV-2 compared to seronegative individuals.</AbstractText><AbstractText Label=\"Conclusion\">Our study utilized well-validated serological platforms to demonstrate that humoral responses to SARS-CoV-2 persisted for at least 7 months. Elevated OC43 and HKU1 antibodies among SARS-CoV-2 seropositive individuals may be attributed to cross reaction and/or boosting of humoral response.</AbstractText><CopyrightInformation>Copyright © 2022 Tanunliong, Liu, Vijh, Pidduck, Kustra, Márquez, Choi, McLennan, Hayden, Kearney, Gantt, Krajden, Morshed, Jassem and Sekirov.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Tanunliong</LastName><ForeName>Guadalein</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vijh</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Office of the Chief Medical Health Officer, Vancouver Coastal Health, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pidduck</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control (BCCDC) Public Health Laboratory, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kustra</LastName><ForeName>Jesse</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control (BCCDC) Public Health Laboratory, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Márquez</LastName><ForeName>Ana Citlali</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control (BCCDC) Public Health Laboratory, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Choi</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Office of the Chief Medical Health Officer, Vancouver Coastal Health, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>McLennan</LastName><ForeName>Meghan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control (BCCDC) Public Health Laboratory, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hayden</LastName><ForeName>Althea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Office of the Chief Medical Health Officer, Vancouver Coastal Health, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kearney</LastName><ForeName>Christy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Haro Park Centre, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gantt</LastName><ForeName>Soren</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre de Recherche de Centre Hospitalier Universitaire (CHU) Sainte-Justine, Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Krajden</LastName><ForeName>Mel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control (BCCDC) Public Health Laboratory, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Morshed</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control (BCCDC) Public Health Laboratory, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jassem</LastName><ForeName>Agatha N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control (BCCDC) Public Health Laboratory, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sekirov</LastName><ForeName>Inna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control (BCCDC) Public Health Laboratory, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000914\">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000369\" MajorTopicYN=\"N\">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000914\" MajorTopicYN=\"N\">Antibodies, Viral</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"Y\">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"N\">COVID-19</DescriptorName><QualifierName UI=\"Q000097\" MajorTopicYN=\"Y\">blood</QualifierName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002170\" MajorTopicYN=\"N\" Type=\"Geographic\">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004196\" MajorTopicYN=\"Y\">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008134\" MajorTopicYN=\"Y\">Long-Term Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086402\" MajorTopicYN=\"N\">SARS-CoV-2</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"Y\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D013997\" MajorTopicYN=\"N\">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"Y\">COVID-19</Keyword><Keyword MajorTopicYN=\"Y\">SARS-CoV-2</Keyword><Keyword MajorTopicYN=\"Y\">human coronavirus (HCoV)</Keyword><Keyword MajorTopicYN=\"Y\">humoral immune response</Keyword><Keyword MajorTopicYN=\"Y\">long term care facilities</Keyword><Keyword MajorTopicYN=\"Y\">outbreak investigation</Keyword><Keyword MajorTopicYN=\"Y\">serologic testing</Keyword></KeywordList><CoiStatement>SG reports having received research support and/or consulting fees from Moderna, Merck, GSK, VBI Vaccines, and Meridian Biosciences. No products of these companies were used in the study. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>09</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35046939</ArticleId><ArticleId IdType=\"doi\">10.3389/fimmu.2021.775420</ArticleId><ArticleId IdType=\"pmc\">PMC8763385</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Clin Virol. 2020 Sep;130:104572</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32769024</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2020 Aug;26(8):1200-1204</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32555424</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2021 Sep 7;73(5):e1208-e1211</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33270134</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep Med. 2021 Jul 20;2(7):100354</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34250512</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2021 Aug 2;73(3):e531-e539</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32745196</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2020 Nov 27;370(6520):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32994364</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1081-1083</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34383732</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Immunol. 2020 Oct 8;5(52):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33033173</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2021 Apr;105:304-306</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33636357</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Med Virol. 2021 Mar;31(2):e2162</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32964627</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2020 Jul;128:104433</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32405254</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2021 Jan;21(1):52-58</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33058797</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2021 Oct;93(10):5953-5960</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34185312</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Infect Control. 2021 May;49(5):649-652</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33086096</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2020 Aug 24;192(34):E973-E979</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32753391</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Geriatr. 2019 Aug 5;19(1):210</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31382895</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2020 Nov 17;53(5):925-933.e4</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33129373</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2021 Aug 6;12(1):4740</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34362897</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem. 2021 Jan 30;67(2):404-414</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33084854</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2021 Apr 17;397(10283):1459-1469</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33844963</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2021 Mar;136:104765</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33636554</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2021 Nov 1;131(21):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34499051</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol Methods. 2021 Feb;288:114025</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33227340</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2021 Oct 29;12(1):6250</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34716320</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2021 Mar;591(7851):639-644</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Microbiol. 2021 Oct 8;75:19-47</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33492978</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2021 Feb 5;371(6529):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 2021 Dec;159:105-112</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34742157</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Immunol. 2021 Jul;41(5):906-913</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33725211</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2021 Feb 19;12(1):1152</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33608538</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"MEDLINE\" IndexingMethod=\"Automated\" Owner=\"NLM\"><PMID Version=\"1\">35039193</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1873-2518</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>40</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>02</Month><Day>07</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and missed or delayed vaccination in 26 middle- and high-income countries: An observational survey.</ArticleTitle><Pagination><MedlinePgn>945-952</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0264-410X(21)01649-2</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.vaccine.2021.12.041</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\">The COVID-19 pandemic has disrupted vaccination services and raised the risk of a global resurgence of preventable diseases. We assessed the extent of and reasons for missed or delayed vaccinations (hereafter 'missed') in middle- and high-income countries in the early months of the pandemic.</AbstractText><AbstractText Label=\"METHODS\">From May to June 2020, participants completed an online survey on missed vaccination. Analyses separated missed childhood and adult vaccination in middle-and high-income countries.</AbstractText><AbstractText Label=\"RESULTS\">Respondents were 28,429 adults from 26 middle- and high-income countries. Overall, 9% of households had missed a vaccine, and 13% were unsure. More households in middle- than high-income countries reported missed childhood vaccination (7.6% vs. 3.0%) and missed adult vaccination (9.6% vs. 3.4%, both p &lt; .05). Correlates of missed childhood vaccination in middle-income countries included COVID-19 risk factors (respiratory and cardiovascular diseases), younger age, male sex, employment, psychological distress, larger household size, and more children. In high-income countries, correlates of missed childhood vaccination also included immunosuppressive conditions, but did not include sex or household size. Fewer correlates were associated with missed adult vaccination other than COVID-19 risk factors and psychological distress. Common reasons for missed vaccinations were worry about getting COVID-19 at the vaccination clinic (15%) or when leaving the house (11%). Other reasons included no healthcare provider recommendation, clinic closure, and wanting to save services for others.</AbstractText><AbstractText Label=\"INTERPRETATION\">Missed vaccination was common and more prevalent in middle- than high-income countries. Missed vaccination could be mitigated by emphasizing COVID-19 safety measures in vaccination clinics, ensuring free and accessible immunization, and clear healthcare provider recommendations.</AbstractText><CopyrightInformation>Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Shapiro</LastName><ForeName>Gilla K</ForeName><Initials>GK</Initials><AffiliationInfo><Affiliation>Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Electronic address: gilla.shapiro@uhnresearch.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gottfredson</LastName><ForeName>Nisha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Leask</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wiley</LastName><ForeName>Kerrie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ganter-Restrepo</LastName><ForeName>Francine E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jones</LastName><ForeName>Sarah P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Institute of Global Health Innovation, Imperial College London, St Mary's Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Menning</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brewer</LastName><ForeName>Noel T</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D064888\">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"Y\">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002648\" MajorTopicYN=\"N\">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D019049\" MajorTopicYN=\"N\">Developed Countries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D058873\" MajorTopicYN=\"N\">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086402\" MajorTopicYN=\"N\">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011795\" MajorTopicYN=\"N\">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D014611\" MajorTopicYN=\"N\">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"Y\">COVID-19</Keyword><Keyword MajorTopicYN=\"Y\">Cross-country analysis</Keyword><Keyword MajorTopicYN=\"Y\">Immunization</Keyword><Keyword MajorTopicYN=\"Y\">Under-vaccination</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest GKS, NG, JL, and KR report consulting fees from the World Health Organization during the conduct of the study. GKS is supported by a Canadian Institutes of Health Research 2019 Fellowship Award (CIHR MFE 171271) outside the submitted work. NB reports consulting fees for Merck, Novartis, Centers for Disease Control and Prevention, and World Health Organization. All other authors declare no conflict of interest. Pharmaceutical companies or other agencies were not involved in the funding of this article. The funders of this study played no role in the study design, data collection, data analysis, data interpretation, or writing of this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>03</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35039193</ArticleId><ArticleId IdType=\"pii\">S0264-410X(21)01649-2</ArticleId><ArticleId IdType=\"doi\">10.1016/j.vaccine.2021.12.041</ArticleId><ArticleId IdType=\"pmc\">PMC8687753</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Curr Med Res Opin. 2021 Dec;37(12):2077-2087</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34538163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Glob Health. 2020 Apr;8(4):e497-e510</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32087815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 May 30;395(10238):1687-1688</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32539939</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Glob Health. 2020 Oct;8(10):e1264-e1272</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32687792</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2021 Feb 1;17(2):400-407</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32845739</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Policy Plan. 2020 Oct 1;35(8):1130-1132</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32832996</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J MCH AIDS. 2020;9(3):381-385</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33014624</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2021 Sep 1;292:552-558</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34147967</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hepatol. 2021 Jan;74(1):31-36</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32777322</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Public Health. 2020 Aug;111(4):469-472</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32761546</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccines (Basel). 2020 Sep 22;8(3):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32972015</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2021 Mar 4;17(3):661-663</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32991237</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccines (Basel). 2020 Oct 03;8(4):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33022916</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Dec 5;396(10265):1782-1784</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33189184</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 Jun 16;369:m2392</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32546575</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychosomatics. 2009 Nov-Dec;50(6):613-21</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19996233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Glob Health. 2020 Sep;8(9):e1118-e1120</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32615076</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2020 Dec 28;15(12):e0244049</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33370323</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2020 May;25(19):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32431288</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2021 Apr;21(4):459-460</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33460565</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2003 Jan 30;21(7-8):596-600</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12531324</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2020 Oct 21;38(45):7146-7155</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32943265</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Perspect Sex Reprod Health. 2020 Apr 16;46:73-76</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32343244</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):591-593</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32407298</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Apr;580(7804):446-447</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32265541</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Glob Health. 2020 Jun;5(6):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32499220</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 Feb 11;368:m268</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32047065</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35035559</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Print\">1810-6838</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>17</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Breathe (Sheffield, England)</Title><ISOAbbreviation>Breathe (Sheff)</ISOAbbreviation></Journal><ArticleTitle>Management of children and adolescents with bronchiectasis: summary of the ERS clinical practice guideline.</ArticleTitle><Pagination><MedlinePgn>210105</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1183/20734735.0105-2021</ELocationID><Abstract><AbstractText>Bronchiectasis, characterised by chronic wet/productive cough with recurrent respiratory exacerbations and abnormal bronchial dilatation on computed tomography scans, remains an increasingly recognised but often neglected chronic pulmonary disorder in children and adolescents. An early diagnosis combined with optimal management offers the prospect, at least in some patients, of curing a condition previously considered irreversible. However, unlike in adults, until now no international paediatric guidelines existed. The recently published European Respiratory Society clinical practice guidelines for the management of children and adolescents with bronchiectasis attempts to address this clinical information gap. The guidelines were formulated by panel members comprised of experts from several relevant health fields, the European Lung Foundation and parents of children with bronchiectasis. Systematic reviews and the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach guided the nature and strength of recommendations. The recommendations are grouped into clinically relevant topics: diagnosis, evaluating for underlying causes, defining exacerbations, management, systematic care, monitoring, reversibility and prevention. The guidelines seek to achieve: 1) optimal lung growth, 2) preserved lung function, 3) enhanced quality of life, 4) minimal exacerbations, 5) few or no complications, and 6) if possible, reversal of lung injury for each child/adolescent with bronchiectasis. This review presents example cases that highlight the recommendations of the clinical practice guidelines.</AbstractText><AbstractText Label=\"EDUCATIONAL AIMS\" NlmCategory=\"UNASSIGNED\">This article is intended for those involved in caring for children/adolescents with bronchiectasis. It aims to inform:Clinicians of the European Respiratory Society recommendations for the diagnosis and management of children/adolescents with bronchiectasis.Adolescents and parents of children/adolescents with bronchiectasis of these recommendations, so as to assist discussions with healthcare teams and help facilitate access to appropriate care.</AbstractText><CopyrightInformation>Copyright ©ERS 2021.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Chang</LastName><ForeName>Anne B</ForeName><Initials>AB</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-1331-3706</Identifier><AffiliationInfo><Affiliation>Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Grimwood</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Depts of Infectious Disease and Paediatrics, Gold Coast Health, Southport, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Dentistry, and Menzies Health Institute Queensland, Griffith University, Gold Coast campus, Southport, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Boyd</LastName><ForeName>Jeanette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>European Lung Foundation, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fortescue</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, St George's University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Powell</LastName><ForeName>Zena</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>European Lung Foundation bronchiectasis paediatric patient advisory group, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kantar</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-3445-4612</Identifier><AffiliationInfo><Affiliation>Pediatric Asthma and Cough Centre, Istituti Ospedalieri Bergamaschi, University and Research Hospitals, Bergamo, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Breathe (Sheff)</MedlineTA><NlmUniqueID>101231007</NlmUniqueID><ISSNLinking>1810-6838</ISSNLinking></MedlineJournalInfo><CoiStatement>Conflict of interest: A.B. Chang reports grants from the National Health and Medical Research Council (NHMRC), Australia, for various project grants and a Centre of Research Excellence relating to various aspects of bronchiectasis in children, as well as an NHMRC Practitioner fellowship (1058213), during the conduct of the study; and fees paid to her institution from GSK (Independent Data Monitoring Committee (IDMC) member for an unlicensed vaccine), Merck (advisory member of study design for an unlicensed molecule for chronic cough), and Moderna (IDMC member for a COVID-19 vaccine for children), outside the submitted work. Conflict of interest: K. Grimwood reports grants from the National Health and Medical Research Council (NHMRC), Australia, for various project grants and a Centre of Research Excellence relating to various aspects of bronchiectasis in children, during the conduct of the study. Conflict of interest: J. Boyd is an employee of the European Lung Foundation. Conflict of interest: R. Fortescue has nothing to disclose. Conflict of interest: Z. Powell has nothing to disclose. Conflict of interest: A. Kantar has nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>06</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>07</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>1</Month><Day>17</Day><Hour>5</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35035559</ArticleId><ArticleId IdType=\"doi\">10.1183/20734735.0105-2021</ArticleId><ArticleId IdType=\"pii\">EDU-0105-2021</ArticleId><ArticleId IdType=\"pmc\">PMC8753694</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pediatr Pulmonol. 2009 Jul;44(7):669-75</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19514055</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Pulmonol. 2012 Mar;47(3):300-7</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21901858</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2011 Jun;139(6):1445-1450</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20864608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2020 May;8(5):493-505</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32380069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2010 Jul;138(1):158-64</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20173055</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2020 Jun 15;201(12):1499-1507</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32097051</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 2019 Jan;74(Suppl 1):1-69</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30545985</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Aug 11;9(8):e104236</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25111142</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2275-85</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26363637</ArticleId></ArticleIdList></Reference><Reference><Citation>ERJ Open Res. 2019 Sep 10;5(3):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31528635</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2018 Jan 31;51(2):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29386336</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr. 2004 Feb;144(2):154-61</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14760252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Am Thorac Soc. 2014 Sep;11(7):1039-48</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24597615</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 2013 Mar;68(3):256-62</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22781123</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr. 2001 May;138(5):699-704</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11343046</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Dis Primers. 2018 Nov 15;4(1):45</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30442957</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Radiol. 2003 Sep;47(3):215-20</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12927665</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Pulmonol. 2008 Jun;43(6):519-31</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18435475</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2013 Oct;1(8):610-620</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24461664</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2021 Aug 26;58(2):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33542057</ArticleId></ArticleIdList></Reference><Reference><Citation>AJR Am J Roentgenol. 2003 Feb;180(2):513-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12540463</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2017 Sep 9;50(3):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28889110</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Pulmonol. 2019 Dec;54(12):1921-1926</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31475469</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiration. 2014;88(1):46-51</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24820893</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 2013 Dec;68(12):1105-13</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23749841</ArticleId></ArticleIdList></Reference><Reference><Citation>Respirology. 2020 Dec;25(12):1250-1256</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32358912</ArticleId></ArticleIdList></Reference><Reference><Citation>Respirology. 2018 Aug;23(8):725-726</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29532561</ArticleId></ArticleIdList></Reference><Reference><Citation>ERJ Open Res. 2021 Jul 19;7(3):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34291113</ArticleId></ArticleIdList></Reference><Reference><Citation>Afr J Paediatr Surg. 2014 Jul-Sep;11(3):225-8</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25047313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2019 Sep;7(9):791-801</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31427252</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Pulmonol. 2014 May;49(5):435-40</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24482322</ArticleId></ArticleIdList></Reference><Reference><Citation>COPD. 2009 Apr;6(2):130-6</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19378226</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2012 Apr;141(4):1018-1024</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21885727</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2018 Sep 8;392(10150):866-879</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30215382</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35035297</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Print\">1537-2073</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>23</Volume><Issue>6</Issue><PubDate><MedlineDate>2021 Nov-Dec</MedlineDate></PubDate></JournalIssue><Title>International journal of MS care</Title><ISOAbbreviation>Int J MS Care</ISOAbbreviation></Journal><ArticleTitle>The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources.</ArticleTitle><Pagination><MedlinePgn>261-268</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.7224/1537-2073.2021-006</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">One of the major objectives of the Multiple Sclerosis Data Alliance (MSDA) is to enable better discovery of multiple sclerosis (MS) real-world data (RWD).</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">We implemented the MSDA Catalogue, which is available worldwide. The current version of the MSDA Catalogue collects descriptive information on governance, purpose, inclusion criteria, procedures for data quality control, and how and which data are collected, including the use of e-health technologies and data on collection of COVID-19 variables. The current cataloguing procedure is performed in several manual steps, securing an effective catalogue.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Herein we summarize the status of the MSDA Catalogue as of January 6, 2021. To date, 38 data sources across five continents are included in the MSDA Catalogue. These data sources differ in purpose, maturity, and variables collected, but this landscaping effort shows that there is substantial alignment on some domains. The MSDA Catalogue shows that personal data and basic disease data are the most collected categories of variables, whereas data on fatigue measurements and cognition scales are the least collected in MS registries/cohorts.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">The Web-based MSDA Catalogue provides strategic overview and allows authorized end users to browse metadata profiles of data cohorts and data sources. There are many existing and arising RWD sources in MS. Detailed cataloguing of MS RWD is a first and useful step toward reducing the time needed to discover MS RWD sets and promoting collaboration.</AbstractText><CopyrightInformation>© 2021 Consortium of Multiple Sclerosis Centers.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Geys</LastName><ForeName>Lotte</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-1919-9366</Identifier><AffiliationInfo><Affiliation>University MS Center, Hasselt-Pelt, Belgium (LG, TParciak, AP, BVW, LMP).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute (BIOMED) (LG, TParciak, AP, BVW, LMP), University of Hasselt, Diepenbeek, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Science Institute (LG, TParciak, AP, LMP), University of Hasselt, Diepenbeek, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Parciak</LastName><ForeName>Tina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University MS Center, Hasselt-Pelt, Belgium (LG, TParciak, AP, BVW, LMP).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute (BIOMED) (LG, TParciak, AP, BVW, LMP), University of Hasselt, Diepenbeek, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Science Institute (LG, TParciak, AP, LMP), University of Hasselt, Diepenbeek, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Medical Center Göttingen, Department of Medical Informatics, Germany (TParciak).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pirmani</LastName><ForeName>Ashkan</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-4549-1002</Identifier><AffiliationInfo><Affiliation>University MS Center, Hasselt-Pelt, Belgium (LG, TParciak, AP, BVW, LMP).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute (BIOMED) (LG, TParciak, AP, BVW, LMP), University of Hasselt, Diepenbeek, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ESAT-STADIUS, KU Leuven, Leuven, Belgium (AP).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>McBurney</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-1747-1004</Identifier><AffiliationInfo><Affiliation>Accelerated Cure Project for MS, Waltham, MA, USA (RM, HS).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schmidt</LastName><ForeName>Hollie</ForeName><Initials>H</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-4467-7374</Identifier><AffiliationInfo><Affiliation>Accelerated Cure Project for MS, Waltham, MA, USA (RM, HS).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Malbaša</LastName><ForeName>Tanja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Association of Multiple Sclerosis Societies of Croatia, Zagreb (TM).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ziemssen</LastName><ForeName>Tjalf</ForeName><Initials>T</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0001-8799-8202</Identifier><AffiliationInfo><Affiliation>Center for Clinical Neuroscience, University Hospital Dresden, Germany (TZ).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bergmann</LastName><ForeName>Arnfin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NeuroTransData Study Group, Neuburg/Donau, Germany (AB).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rojas</LastName><ForeName>Juan I</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Neurology Department, Hospital Universitario de CEMIC, Buenos Aires, Argentina (JIR).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cristiano</LastName><ForeName>Edgardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>MS Center of Buenos Aires (CEMBA), Argentina (EC).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>García-Merino</LastName><ForeName>Juan Antonio</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Universidad Autonoma de Madrid, Spain (JAG-M).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Service, Puerta de Hierro Hospital, Majadahonda, Madrid, Spain (JAG-M).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fernández</LastName><ForeName>Óscar</ForeName><Initials>Ó</Initials><AffiliationInfo><Affiliation>University of Malaga, Department of Pharmacology, Spain (OF).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kuhle</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland (JK).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gobbi</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Multiple Sclerosis Center, Department of Neurology, Neurocenter of Southern Switzerland, Lugano, Switzerland (CG).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (CG).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Delmas</LastName><ForeName>Amber</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Life Sciences Department, EHealthLine.com, Inc (AD).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Simpson-Yap</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroepidemiology Unit, Melbourne School of Population and Global Health, The University of Melbourne, Australia (SS-Y, NN).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Nag</LastName><ForeName>Nupur</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-0271-0781</Identifier><AffiliationInfo><Affiliation>Neuroepidemiology Unit, Melbourne School of Population and Global Health, The University of Melbourne, Australia (SS-Y, NN).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yamout</LastName><ForeName>Bassem</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Multiple Sclerosis Center, American University of Beirut Medical Center, Lebanon (BY).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Steinemann</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Data Center of the Swiss Multiple Sclerosis Registry, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland (NS).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Seeldrayers</LastName><ForeName>Pierrette</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, CHU de Charleroi, Charleroi, Belgium (PS).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dubois</LastName><ForeName>Bénédicte</ForeName><Initials>B</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-0604-8702</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Laboratory for Neuroimmunology, KU Leuven, Leuven, Belgium (BD).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leuven Brain Institute KU Leuven, Leuven, Belgium (BD).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium (BD).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>van der Mei</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0001-9009-7472</Identifier><AffiliationInfo><Affiliation>Menzies Institute for Medical Research, University of Tasmania, Hobart TAS, Australia (IvdM).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stahmann</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German MS-Registry, MS Forschungs- und Projektentwicklungs-gGmbH, Hannover, Germany (AS).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Drulovic</LastName><ForeName>Jelena</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinic of Neurology, Clinical Center of Serbia, Belgrade, Serbia (JD).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pekmezovic</LastName><ForeName>Tatjana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia (TPekmezovic).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brola</LastName><ForeName>Waldemar</ForeName><Initials>W</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-7955-3454</Identifier><AffiliationInfo><Affiliation>Collegium Medicum, Jan Kochanowski University, Kielce, Poland (WB).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tintore</LastName><ForeName>Mar</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0001-9999-5359</Identifier><AffiliationInfo><Affiliation>Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Edifici Cemcat, Hospital Universitari Vall d'Hebron, Barcelona, Spain (MT).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kalkers</LastName><ForeName>Nynke</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0001-6420-7914</Identifier><AffiliationInfo><Affiliation>Department of Neurology, OLVG, and Department of Neurology, Amsterdam UMC, Location VUMC, Amsterdam, the Netherlands (NK).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ivanov</LastName><ForeName>Rumen</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>PMA - Pharma Marketing Advisors, Ltd, Sofia, Bulgaria (RI).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zakaria</LastName><ForeName>Magd</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ain Shams University, Egypt (MZ).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Naseer</LastName><ForeName>Maged Abdel</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Cairo University, Egypt (MAN).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Van Hecke</LastName><ForeName>Wim</ForeName><Initials>W</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-3058-0937</Identifier><AffiliationInfo><Affiliation>icometrix, Leuven, Belgium (WVH).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Grigoriadis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-4278-3301</Identifier><AffiliationInfo><Affiliation>Second Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General University Hospital, Thessaloniki Greece (NG, MB).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Boziki</LastName><ForeName>Marina</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-6601-5163</Identifier><AffiliationInfo><Affiliation>Second Neurological University Department, Multiple Sclerosis Center, Aristotle University of Thessaloniki, AHEPA General University Hospital, Thessaloniki Greece (NG, MB).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Carra</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-3874-4884</Identifier><AffiliationInfo><Affiliation>MS Center Hospital Britanico, Buenos Aires, Argentina (AC).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pawlak</LastName><ForeName>Mikolaj A</ForeName><Initials>MA</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-8607-0194</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Cerebrovascular Disorders, Poznan University of Medical Sciences, Poznan, Poland (MAP).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dobson</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Wolfson Institute of Preventive Medicine, Charterhouse Square, London, UK (RD).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hellwig</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0003-4467-9011</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Katholisches Klinikum, St Josef Hospital, Ruhr University Bochum, Bochum Germany (KH).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gallagher</LastName><ForeName>Arlene</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Practice Research Datalink (CPRD), Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK (AG).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Leocani</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Neurology Unit, San Raffaele University, Milan, Italy (LL, GDC).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dalla Costa</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Universitário Getulio Vargas, Manaus/Amazonas, Brazil (NAdCS).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>de Carvalho Sousa</LastName><ForeName>Nise Alessandra</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>REDONE - Brazilian Registry of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders, São Paulo, Brazil (NAdCS).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Van Wijmeersch</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University MS Center, Hasselt-Pelt, Belgium (LG, TParciak, AP, BVW, LMP).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute (BIOMED) (LG, TParciak, AP, BVW, LMP), University of Hasselt, Diepenbeek, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Noorderhart, Rehabilitation and MS Center, Pelt, Belgium (BVW).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Peeters</LastName><ForeName>Liesbet M</ForeName><Initials>LM</Initials><Identifier Source=\"ORCID\">https://orcid.org/0000-0002-6066-3899</Identifier><AffiliationInfo><Affiliation>University MS Center, Hasselt-Pelt, Belgium (LG, TParciak, AP, BVW, LMP).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute (BIOMED) (LG, TParciak, AP, BVW, LMP), University of Hasselt, Diepenbeek, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Data Science Institute (LG, TParciak, AP, LMP), University of Hasselt, Diepenbeek, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>12</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J MS Care</MedlineTA><NlmUniqueID>101132980</NlmUniqueID><ISSNLinking>1537-2073</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Catalog</Keyword><Keyword MajorTopicYN=\"N\">Multiple sclerosis (MS)</Keyword><Keyword MajorTopicYN=\"N\">Real-world data</Keyword><Keyword MajorTopicYN=\"N\">Registry</Keyword></KeywordList><CoiStatement>Financial Disclosures: Dr Geys is funded by the Flemish Government under the “Onderzoeksprogramma Artificiële Intelligentie Vlaanderen.” Ms Parciak and Mr Pirmani are funded by the Fonds voor Wetenschappelijk Onderzoek (FWO) (project R4859). Dr McBurney is the chief research officer and Ms Schmidt is the vice president of scientific operations of the Accelerated Cure Project for MS (ACP). Dr McBurney has received consulting payments from EMD Serono, which have been donated to the ACP. The ACP has received grants, collaboration funding, payments for use of assets, or in-kind contributions from the following companies: EMD Serono, Novartis, Sanofi/Genzyme, Biogen, Genentech, AbbVie, Octave, GlycoMinds, Pfizer, MedDay, AstraZeneca, Teva, Mallinckrodt, MSDx, Regeneron Genetics Center, BC Platforms, and Bristol Myers Squibb (Celgene). The ACP has also received funding from the Patient-Centered Outcomes Research Institute, the National MS Society, and the Italian MS Society. Dr Rojas has received reimbursement for developing educational presentations, educational and research grants, consultation fees, and travel stipends from Biogen, Genzyme, Merck, and Novartis. Dr García-Merino has received honoraria for travel expenses, lecturing, or consulting from Merck, Biogen, Bayer, Teva, Roche, Novartis, Genzyme, and Almirall and research grants from Biogen and Novartis. Dr Fernández has received travel support and/or research grants and/or lecture fees and/or advisory services from Merck, Bayer, Biogen, Teva, Sanofi Genzyme, Novartis, Roche, Almirall, Allergan, Orizon, and Araclon. Dr Gobbi’s employer (Department of Neurology, Regional Hospital Lugano [EOC], Switzerland) receives financial support for speaking or educational, research, or travel grants from AbbVie, Almirall, Biogen, Celgene, Sanofi, Merck, Novartis, Teva, and Roche. The Neuroepidemiology Unit and HOLISM-related work (Drs Simpson-Yap and Nag) was supported by anonymous philanthropic funders and Mr Wal Pisciotta. Dr Yamout has received speaker honoraria from Bayer, Biogen, Genesis Pharma, Genpharm, Genzyme, Merck, and Novartis; research grants from Bayer, Biogen, Merck, Novartis, and Pfizer; and advisory board honoraria from Bayer, Biogen, Genzyme, Merck, Novartis, and Genpharm. The Swiss MS Registry (Dr Steinemann) is funded by a grant from the Swiss Multiple Sclerosis Society. Dr Seeldrayers has been responsible for BELTRIMS in the frame of the Belgian Study Group for Multiple Sclerosis; in the frame of her clinical activities, she has received travel grants and honoraria for lectures and participation in advisory boards from Biogen, Bayer, Merck, Teva, Sanofi Genzyme, Novartis, and Roche. Dr Dubois is a clinical investigator of the Research Fund Flanders (FWO-Vlaanderen). Mr Stahmann is the lead of the German MS Registry, which receives funding from a range of public and corporate sponsors, recently including the German Innovation Fund, German MS Trust, German MS Society, Biogen, Celgene (Bristol Myers Squibb), Merck, Novartis, Roche, and Sanofi. Dr Drulovic has received travel support and/or research grants and/or lecture fees and/or advisory services from Novartis, Bayer, Merck, Sanofi Genzyme, Roche, Teva, Medis, Hemofarm, and Medtronic. Dr Pekmezovic has received travel support and/or research grants and/or lecture fees and/or advisory services from Novartis, Merck, Sanofi Genzyme, Roche, Teva, and Hemofarm. Dr Tintore discloses consulting services and speaking honoraria from Almirall, Bayer Schering Pharma, Biogen, Genzyme, Janssen, Merck-Serono, Novartis, Roche, Sanofi-Aventis, Viela Bio, and Teva and research grants and support from Carlos III Health Institute, Foundation Genzyme, Foundation Salud 2000, Biogen, and Novartis. Dr Kalkers received speaking fees and consulting fees from Novartis, Teva, and Sanofi Genzyme. The Dutch MS Registry is funded by a project from ZonMW and co-financed by Biogen, Celgene, Merck, Mylan, Novartis, Roche, Sanofi Genzyme, and Teva. Dr Zakaria has received fees for lectures and advisory board meetings from Merck, Roche, Sanofi, Biogen, Novartis, and Bayer. Dr Naseer received speaker honoraria and served on scientific advisory boards for Novartis, Roche, Merck, Sanofi Genzyme, and Bayer. Dr Grigoriadis has received travel support and/or honoraria and/or research grants and/or lecture fees and/or advisory services and/or consulting fees from Novartis, Bayer, Merck, Genesis, Sanofi, Specifar, Roche, Biogen, Teva, Mylan, Merck Serono, Sanofi Genzyme, Celgene, and ELPEN. Dr Boziki has received travel support and/or research grants and/or lecture fees and/or advisory services from the Hellenic Foundation for Research and Innovation, the Ministry of Education’s Education and Lifelong Learning Program, the Hellenic Neurological Society, the Hellenic Academy of Neuroimmunology, Biogen, Novartis, Teva, Bayer, Genesis Pharma, Sanofi, Specifar, Roche, and Merck. Dr Pawlak has received grants from the Polish National Science Centre during the conduct of the study as well as personal fees from Roche, Novartis, Merck, and Biogen outside the submitted work. Dr Dobson has received travel support and/or research grants and/or consulting fees from Biogen, Roche, Celgene, Sanofi Genzyme, Teva, and Merck. Dr Hellwig has received travel support and/or research grants and/or lecture fees and/or advisory services from Novartis, Bayer, Merck, Sanofi Genzyme, Roche, Biogen, Teva, and Mylan. Dr Leocani has received consulting fees and/or research support from Biogen, Merck KGgA, Novartis, Hoffman-La Roche, Almirall SpA, and Bristol Myers Squibb. Dr Van Wijmeersch has received travel support and/or research grants and/or lecture fees and/or advisory services from Almirall, Biogen, Bristol Myers Squibb, Janssen Pharmaceutica, Merck, Novartis, Roche, Sanofi, and Teva. Dr Peeters is chair of the MSDA, which receives income from a range of corporate sponsors, including Biogen, Bristol Myers Squibb, Janssen, Merck KGaA, Mylan, Novartis, QMENTA, and Roche and has received funding from the Flemish Government under the “Onderzoeksprogramma Artificiële Intelligentie Vlaanderen.” The other authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>1</Month><Day>17</Day><Hour>5</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35035297</ArticleId><ArticleId IdType=\"doi\">10.7224/1537-2073.2021-006</ArticleId><ArticleId IdType=\"pmc\">PMC8745233</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Med Inform Assoc. 2012 Jan-Feb;19(1):54-60</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Relat Disord. 2021 Jan;47:102634</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33278741</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurol. 2020 Mar;16(3):171-182</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32094485</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Technol Assess Health Care. 2014 Nov;30(5):514-20</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25747561</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2020 Jan;26(1):23-37</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31778094</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2011 Oct;10(10):865</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21939893</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Inform Assoc. 2016 Sep;23(5):909-15</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2021 Feb;27(2):281-289</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32163003</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2019 Nov;18(11):981</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31609205</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Jul 24;13(7):e0200926</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30040866</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2018 Oct;24(11):1469-1484</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28799444</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2014 Oct;20(11):1523-32</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24777278</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2018 Apr;24(5):579-586</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28279128</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler. 2020 Sep;26(10):1157-1162</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32662757</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):245-252</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29327451</ArticleId></ArticleIdList></Reference><Reference><Citation>Mult Scler Relat Disord. 2019 Jan;27:171-178</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30384204</ArticleId></ArticleIdList></Reference><Reference><Citation>Learn Health Syst. 2019 Dec 25;4(2):e10214</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32313838</ArticleId></ArticleIdList></Reference><Reference><Citation>AMIA Annu Symp Proc. 2017 Feb 10;2016:864-873</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28269883</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2021 Nov 9;97(19):e1870-e1885</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34610987</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35013735</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2667-193X</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>1</Volume><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Lancet Regional Health. Americas</Title><ISOAbbreviation>Lancet Reg Health Am</ISOAbbreviation></Journal><ArticleTitle>Phylogenetic estimates of SARS-CoV-2 introductions into Washington State.</ArticleTitle><Pagination><MedlinePgn>100018</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.lana.2021.100018</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">The first confirmed case of SARS-CoV-2 in North America was identified in Washington state on January 21, 2020. We aimed to quantify the number and temporal trends of out-of-state introductions of SARS-CoV-2 into Washington.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">We conducted a molecular epidemiologic analysis of 11,422 publicly available whole genome SARS-CoV-2 sequences from GISAID sampled between December 2019 and September 2020. We used maximum parsimony ancestral state reconstruction methods on time-calibrated phylogenies to enumerate introductions/exports, their likely geographic source (US, non-US, and between eastern and western Washington), and estimated date of introduction. To incorporate phylogenetic uncertainty into our estimates, we conducted 5,000 replicate analyses by generating 25 random time-stratified samples of non-Washington reference sequences, 20 random polytomy resolutions, and 10 random resolutions of the reconstructed ancestral state.</AbstractText><AbstractText Label=\"FINDINGS\" NlmCategory=\"RESULTS\">We estimated a minimum 287 introductions (range 244-320) into Washington and 204 exported lineages (range 188-227) of SARS-CoV-2 out of Washington. Introductions began in mid-January and peaked on March 29, 2020. Lineages with the Spike D614G variant accounted for the majority (88%) of introductions. Overall, 61% (range 55-65%) of introductions into Washington likely originated from a source elsewhere within the US, while the remaining 39% (range 35-45%) likely originated from outside of the US. Intra-state transmission accounted for 65% and 28% of introductions into eastern and western Washington, respectively.</AbstractText><AbstractText Label=\"INTERPRETATION\" NlmCategory=\"CONCLUSIONS\">The SARS-CoV-2 epidemic in Washington was continually seeded by a large number of introductions. Our findings highlight the importance of genomic surveillance to monitor for emerging variants due to high levels of inter- and intra-state transmission of SARS-CoV-2.</AbstractText><AbstractText Label=\"FUNDING SOURCE\" NlmCategory=\"BACKGROUND\">None.</AbstractText><CopyrightInformation>© 2021 The Authors. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Tordoff</LastName><ForeName>Diana M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>University of Washington, Department of Epidemiology, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Disease Modeling, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Greninger</LastName><ForeName>Alexander L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>University of Washington, Department of Laboratory Medicine &amp; Pathology, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Roychoudhury</LastName><ForeName>Pavitra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Washington, Department of Laboratory Medicine &amp; Pathology, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shrestha</LastName><ForeName>Lasata</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Washington, Department of Laboratory Medicine &amp; Pathology, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xie</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Washington, Department of Laboratory Medicine &amp; Pathology, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jerome</LastName><ForeName>Keith R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>University of Washington, Department of Laboratory Medicine &amp; Pathology, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Breit</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Washington, Department of Laboratory Medicine &amp; Pathology, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Huang</LastName><ForeName>Meei-Li</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>University of Washington, Department of Laboratory Medicine &amp; Pathology, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Famulare</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Disease Modeling, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Herbeck</LastName><ForeName>Joshua T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Institute for Disease Modeling, Seattle, WA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Clinical Research Center, University of Washington, Department of Global Health, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>R01 AI127232</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Reg Health Am</MedlineTA><NlmUniqueID>9918232503006676</NlmUniqueID><ISSNLinking>2667-193X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType=\"UpdateOf\"><RefSource>medRxiv. 2021 Apr 07;:</RefSource><PMID Version=\"1\">33855313</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Genomic analysis</Keyword><Keyword MajorTopicYN=\"N\">Molecular epidemiology</Keyword><Keyword MajorTopicYN=\"N\">Phylogeography</Keyword><Keyword MajorTopicYN=\"N\">SARS-CoV-2</Keyword></KeywordList><CoiStatement>ALG reports personal fees from Abbott Molecular, grants from Merck, grants from Gilead, outside the submitted work. DMT, PR, LS, HX, KRJ, NB, MLH, MF and JTH have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>04</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2021</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>06</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35013735</ArticleId><ArticleId IdType=\"doi\">10.1016/j.lana.2021.100018</ArticleId><ArticleId IdType=\"pii\">S2667-193X(21)00010-7</ArticleId><ArticleId IdType=\"pmc\">PMC8733893</ArticleId></ArticleIdList><?pmcsd ?><ReferenceList><Reference><Citation>Science. 2020 Oct 30;370(6516):564-570</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32912998</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Evol. 2013 Apr;30(4):772-80</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23329690</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2020 Jul 31;369(6503):582-587</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32513865</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2020 Sep 4;369(6508):1255-1260</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32703910</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2021 Mar 12;19(3):e3001115</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33711012</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Microbiol. 2020 Nov;5(11):1403-1407</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32669681</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2021 May 26;13(595):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33941621</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2020 Jul 17;369(6501):297-301</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32471856</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2020 Sep;231(3):316-324.e1</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32561446</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 May 21;382(21):2005-2011</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32220208</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23652-23662</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32868447</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2021 Feb 12;371(6530):708-712</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33419936</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Jun 9;323(22):2334-2336</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32383728</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 May 28;181(5):990-996.e5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32386545</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Evol. 2020 May 1;37(5):1530-1534</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32011700</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24614-24616</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32958678</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2021 Feb 5;371(6529):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33303686</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2020 Oct 30;370(6516):571-575</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32913002</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"MEDLINE\" IndexingMethod=\"Automated\" Owner=\"NLM\"><PMID Version=\"1\">35007996</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2059-7029</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>02</Month></PubDate></JournalIssue><Title>ESMO open</Title><ISOAbbreviation>ESMO Open</ISOAbbreviation></Journal><ArticleTitle>The impact of COVID-19 on oncology professionals-one year on: lessons learned from the ESMO Resilience Task Force survey series.</ArticleTitle><Pagination><MedlinePgn>100374</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S2059-7029(21)00336-7</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.esmoop.2021.100374</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\">COVID-19 has had a significant impact on the well-being and job performance of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration set out to investigate and monitor well-being since COVID-19 in relation to work, lifestyle and support factors in oncology professionals 1 year on since the start of the pandemic.</AbstractText><AbstractText Label=\"METHODS\">An online, anonymous survey was conducted in February/March 2021 (Survey III). Key outcome variables included risk of poor well-being or distress (expanded Well-Being Index), feeling burnout (single item from expanded Well-Being Index), and job performance since COVID-19. Longitudinal analysis of responses to the series of three surveys since COVID-19 was carried out, and responses to job demands and resources questions were interrogated. SPSS V.26.0/V.27.0 and GraphPad Prism V9.0 were used for statistical analyses.</AbstractText><AbstractText Label=\"RESULTS\">Responses from 1269 participants from 104 countries were analysed in Survey III: 55% (n = 699/1269) female, 54% (n = 686/1269) &gt;40 years, and 69% (n = 852/1230) of white ethnicity. There continues to be an increased risk of poor well-being or distress (n = 464/1169, 40%) and feeling burnout (n = 660/1169, 57%) compared with Survey I (25% and 38% respectively, P &lt; 0.0001), despite improved job performance. Compared with the initial period of the pandemic, more participants report feeling overwhelmed with workload (45% versus 29%, P &lt; 0.0001). There remain concerns about the negative impact of the pandemic on career development/training (43%), job security (37%). and international fellowship opportunities (76%). Alarmingly, 25% (n = 266/1086) are considering changing their future career with 38% (n = 100/266) contemplating leaving the profession.</AbstractText><AbstractText Label=\"CONCLUSION\">Oncology professionals continue to face increased job demands. There is now significant concern regarding potential attrition in the oncology workforce. National and international stakeholders must act immediately and work closely with oncology professionals to draw up future-proof recovery plans.</AbstractText><CopyrightInformation>Copyright © 2021. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Lim</LastName><ForeName>K H J</ForeName><Initials>KHJ</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Immunology and Inflammation, Imperial College London, London, UK; Immunobiology Laboratory, The Francis Crick Institute, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Murali</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Victorian Clinical Genetics Services &amp; Murdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Thorne</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Punie</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. Electronic address: https://twitter.com/kevinpunie.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kamposioras</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Oing</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Mildred Scheel Cancer Career Centre HaTriCs4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: https://twitter.com/OingC1.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>O'Connor</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital Waterford, Waterford, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Élez</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: https://twitter.com/elena_elez.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Amaral</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University Hospital Tübingen, Tübingen, Germany. Electronic address: https://twitter.com/TeresaSAmaral.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Garrido</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Oncology, Hospital Ramón y Cajal, IRYCIS, Alcalá University, Madrid, Spain. Electronic address: https://twitter.com/Piuchagarrido.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lambertini</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genoa, Genoa, Italy. Electronic address: https://twitter.com/matteolambe.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Devnani</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, Jodhpur, India. Electronic address: https://twitter.com/devnani_bharti.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Westphalen</LastName><ForeName>C B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany. Electronic address: https://twitter.com/BenWestphalen.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Morgan</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Radiation Oncology, Skåne University Hospital, Lund, Sweden. Electronic address: https://twitter.com/weoncologists.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Haanen</LastName><ForeName>J B A G</ForeName><Initials>JBAG</Initials><AffiliationInfo><Affiliation>Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: https://twitter.com/HaanenJohn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hardy</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Banerjee</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK. Electronic address: susana.banerjee@rmh.nhs.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ESMO Open</MedlineTA><NlmUniqueID>101690685</NlmUniqueID><ISSNLinking>2059-7029</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D002055\" MajorTopicYN=\"Y\">Burnout, Professional</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000086382\" MajorTopicYN=\"Y\">COVID-19</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005060\" MajorTopicYN=\"N\" Type=\"Geographic\">Europe</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006282\" MajorTopicYN=\"Y\">Health Personnel</DescriptorName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008495\" MajorTopicYN=\"Y\">Medical Oncology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D058873\" MajorTopicYN=\"N\">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012955\" MajorTopicYN=\"N\">Societies, Medical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"Y\">COVID-19</Keyword><Keyword MajorTopicYN=\"Y\">burnout</Keyword><Keyword MajorTopicYN=\"Y\">job performance</Keyword><Keyword MajorTopicYN=\"Y\">oncology professionals</Keyword><Keyword MajorTopicYN=\"Y\">resilience</Keyword><Keyword MajorTopicYN=\"Y\">well-being</Keyword></KeywordList><CoiStatement>Disclosure KHJL is currently funded by the Wellcome-Imperial 4i Clinical Research Fellowship, and reports speaker honorarium from Janssen, outside the submitted work. KP’s institution received speaker fees or honoraria for consultancy/advisory roles from AstraZeneca, Eli Lilly, Gilead Sciences, Medscape, Merck Sharp &amp; Dohme (MSD), Novartis, Pfizer, Pierre Fabre, Hoffmann La Roche, Mundipharma, PharmaMar, Seagen, Teva, and Vifor Pharma; KP’s institution received research grants from MSD and Sanofi; KP received travel support from AstraZeneca, Novartis, Pfizer, PharmaMar, and Roche; all outside the submitted work. CO reports research funding and honoraria from Roche; travel grant and honoraria from medac Pharma and Ipsen Pharma; and travel grant from PharmaMar; outside the submitted work. EÉ reports speaker honoraria, travel support and advisory board: Bayer, Roche, Servier, Amgen, Pierre-Fabre, Sanofi Aventis, MSD, and Merck Serono; outside the submitted work. TA reports personal fees from Pierre Fabre and CeCaVa; personal fees and travel grants from Bristol Myers Squibb (BMS); grants, personal fees, and travel grants from Novartis; and grants from NeraCare, Sanofi, and SkylineDx; all outside the submitted work. PG reports personal fees from Roche, MSD, BMS, Boerhinger-Ingelheim, Pfizer, AbbVie, Novartis, Lilly, AstraZeneca, Janssen, Blueprint Medicines, Takeda, Gilead, and ROVI, outside the submitted work. ML acted as a consultant for Roche, AstraZeneca, Lilly, and Novartis, and received honoraria from Theramex, Roche, Novartis, Takeda, Pfizer, Sandoz, and Lilly, outside the submitted work. CBW reports speaker honoraria, travel support, and participation in advisory boards: Bayer, BMS, Celgene, GlaxoSmithKline (GSK), Merck, Rafael, RedHil, Roche, Servier, Shire/Baxalta, Sirtex, and Taiho, as well as research support from Roche, outside the submitted work. JBAGH reports personal fees for advisory role in Neogene Tx; grants and fees paid to institution from BMS, MSD, Novartis, BioNTech, Amgen; and fees paid to institution from Achilles Tx, GSK, Immunocore, Ipsen, Merck Serono, Molecular Partners, Pfizer, Roche/Genentech, Sanofi, Seattle Genetics, Third Rock Ventures, Vaximm; outside the submitted work. CH reports being Director of a private company Hardy People Ltd, outside the submitted work. SB reports research grant (institution) from AstraZeneca, Tesaro, and GSK; honoraria for advisory boards or lectures from Amgen, AstraZeneca, Genmab, Immunogen, Mersana, MSD, Merck Serono, OncXerna, Pfizer, Roche, Shattuck Labs, Clovis, Takeda outside the submitted work. KM, KK, MOC, ET, BD, and GM have declared no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2021</Year><Month>12</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>12</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>1</Month><Day>10</Day><Hour>20</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35007996</ArticleId><ArticleId IdType=\"pii\">S2059-7029(21)00336-7</ArticleId><ArticleId IdType=\"doi\">10.1016/j.esmoop.2021.100374</ArticleId><ArticleId IdType=\"pmc\">PMC8677468</ArticleId></ArticleIdList></PubmedData></PubmedArticle>\n",
      "<MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">35004791</PMID><DateRevised><Year>2022</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Print\">2296-858X</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>8</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective.</ArticleTitle><Pagination><MedlinePgn>812370</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.3389/fmed.2021.812370</ELocationID><Abstract><AbstractText>To evaluate the effect of the COVID-19 pandemic on clinical development, the number of newly started clinical trials in each geographical region between January 2018 and December 2020 were calculated based on data from the ClinicalTrials.gov database. Data regarding new drug applications were obtained from European Medicines Agency monthly reports, pharmaceutical company press releases, and the archives of the Drugs.com database. The mean percentage change in newly started clinical trials for diseases other than COVID-19 between each month in 2019 and the corresponding month in 2020 was -7.5%, with the maximum of -57.3% observed between April 2019 and April 2020. Similarly, the mean percentage change of reported results for each month in 2019 and 2020 was -5.1%, with the maximum of -27.4% observed in July 2020. The activity of clinical trials was decreased as the number of COVID-19 patients was increased, and a statistically negative correlation was observed between the prevalence of COVID-19 and the percentage decrease in the number of clinical trials stared or reported results. As for new drug submissions, decreases were observed in the latter half of 2020 compared with the same period during the previous year, for each indicator. A considerable decline in non-COVID-19 activity for all indicators regarding clinical developments was suggested during the first wave of the COVID-19 pandemic. It is important to recognize the situation and continue to make efforts to conduct clinical trials for both COVID-19 and no-COVID-19 for new medical developments in the future.</AbstractText><CopyrightInformation>Copyright © 2021 Nishiwaki and Ando.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Nishiwaki</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ando</LastName><ForeName>Yuichi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>12</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">COVID-19 pandemic</Keyword><Keyword MajorTopicYN=\"N\">clinical development</Keyword><Keyword MajorTopicYN=\"N\">clinical trial</Keyword><Keyword MajorTopicYN=\"N\">new drug application</Keyword><Keyword MajorTopicYN=\"N\">non-COVID-19 activity</Keyword></KeywordList><CoiStatement>YA reports grants and personal fees from Chugai Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Nippon Kayaku Co., Ltd., Yakult Honsha Co., Ltd., Eli Lilly Japan K.K., Mochida Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., and Taiho Pharmaceutical Co., Ltd., personal fees from Novartis Pharma K.K., Merck Serono Co., Ltd., Bayer Holding Ltd., Bristol-Myers Squibb, Otsuka Holdings Co., Ltd., and Sawai Pharmaceutical Co., Ltd., grants and personal fees from Daiichi Sankyo Company, Ltd., grants from Eisai Co., Ltd., Hisamitsu Pharmaceutical Co., Inc., and Takeda Pharmaceutical Co., Ltd., personal fees from Tsumura &amp; Co., Shionogi &amp; Co., Ltd., Janssen Pharmaceutical K.K., and Pharma International Inc., outside the submitted work. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>12</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>1</Month><Day>10</Day><Hour>9</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35004791</ArticleId><ArticleId IdType=\"doi\">10.3389/fmed.2021.812370</ArticleId><ArticleId IdType=\"pmc\">PMC8739772</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Drug Discov Today. 2021 Feb;26(2):593-603</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33253920</ArticleId></ArticleIdList></Reference><Reference><Citation>Turk J Emerg Med. 2018 Aug 07;18(3):91-93</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30191186</ArticleId></ArticleIdList></Reference><Reference><Citation>Appl Intell (Dordr). 2021 May 7;:1-12</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34764597</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2021 Jan;40(1):25-32</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33211535</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Mol Med. 2020 May;26(5):483-495</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32359479</ArticleId></ArticleIdList></Reference><Reference><Citation>Malawi Med J. 2012 Sep;24(3):69-71</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23638278</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Nov 7;396(10261):1525-1534</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32979936</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Nov 17;375(20):1998-2004</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27635471</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2021 Jan;26(1):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33413740</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2021 Jan 4;4(1):e2036155</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33443576</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Med (Lausanne). 2020 Dec 23;7:598038</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33425945</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Agent Cancer. 2020 Dec 1;15(1):73</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33292374</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Jun 2;323(21):2135-2136</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32211830</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccines (Basel). 2021 Jan 11;9(1):</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33440895</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Jan 14;323(2):164-176</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31935033</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Intern Med. 2019 Aug 1;179(8):1144-1146</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31157824</ArticleId></ArticleIdList></Reference><Reference><Citation>J Res Health Sci. 2020 Sep 30;20(3):e00483</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33169715</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Oct 6;324(13):1330-1341</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32876694</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1909 Jul 2;30(757):23-5</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17838275</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2021 Jan 15;22(1):59</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33451350</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2020 Oct 21;15(10):e0241031</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33085731</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2020 Nov 3;10(11):e043560</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33148769</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2021 Aug 10;326(6):499-518</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34228774</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2021 Jan 30;397(10272):355-357</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33453149</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2003 Nov 15;21(22):4145-50</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14559889</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>\n"
     ]
    }
   ],
   "source": [
    "# print(id_list)\n",
    "id_temp_list = []\n",
    "for iden in id_list:\n",
    "    id_temp_list.append(iden.text)\n",
    "id_string = \",\".join(id_temp_list)\n",
    "# print(id_string)\n",
    "\n",
    "fetch_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=\"+id_string+\"&rettype=xml\"\n",
    "fetch_resp = requests.get(fetch_url).text\n",
    "fetch_resp\n",
    "fetch_resp[:2500]\n",
    "fetch_obj = bs(fetch_resp,features=\"lxml\")\n",
    "for i in fetch_resp.split('<PubmedArticle>'):\n",
    "    print(i)\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "pub_date [<daterevised><year>2022</year><month>04</month><day>21</day></daterevised>, <daterevised><year>2022</year><month>04</month><day>08</day></daterevised>, <daterevised><year>2022</year><month>04</month><day>07</day></daterevised>, <daterevised><year>2022</year><month>04</month><day>07</day></daterevised>, <daterevised><year>2022</year><month>04</month><day>07</day></daterevised>, <daterevised><year>2022</year><month>04</month><day>07</day></daterevised>, <daterevised><year>2022</year><month>03</month><day>18</day></daterevised>, <daterevised><year>2022</year><month>03</month><day>10</day></daterevised>, <daterevised><year>2022</year><month>02</month><day>24</day></daterevised>, <daterevised><year>2022</year><month>02</month><day>05</day></daterevised>, <daterevised><year>2022</year><month>02</month><day>05</day></daterevised>, <daterevised><year>2022</year><month>02</month><day>07</day></daterevised>, <daterevised><year>2022</year><month>02</month><day>01</day></daterevised>, <daterevised><year>2022</year><month>01</month><day>24</day></daterevised>, <daterevised><year>2022</year><month>02</month><day>18</day></daterevised>, <daterevised><year>2022</year><month>04</month><day>30</day></daterevised>, <daterevised><year>2022</year><month>04</month><day>30</day></daterevised>, <daterevised><year>2022</year><month>04</month><day>30</day></daterevised>, <daterevised><year>2022</year><month>03</month><day>10</day></daterevised>, <daterevised><year>2022</year><month>01</month><day>11</day></daterevised>]\n",
      "['21-04-2022', '08-04-2022', '07-04-2022', '07-04-2022', '07-04-2022', '07-04-2022', '18-03-2022', '10-03-2022', '24-02-2022', '05-02-2022', '05-02-2022', '07-02-2022', '01-02-2022', '24-01-2022', '18-02-2022', '30-04-2022', '30-04-2022', '30-04-2022', '10-03-2022', '11-01-2022']\n",
      "<class 'bs4.BeautifulSoup'>\n"
     ]
    }
   ],
   "source": [
    "iden = fetch_obj.find_all(\"pmid\")\n",
    "id_list=[i.contents[0] for i in iden]\n",
    "# for i in iden:\n",
    "#     print(i.contents[])\n",
    "#     break\n",
    "# print(id_list)\n",
    "titles = fetch_obj.find_all(\"articletitle\")\n",
    "title_list=[i.contents[0] for i in titles]\n",
    "# print(title_list)\n",
    "\n",
    "pub_date = fetch_obj.find_all(\"daterevised\")\n",
    "print('pub_date',pub_date)\n",
    "\n",
    "pub_date_list=[i.contents[2].next_element+'-'+i.contents[1].next_element+\"-\"+i.contents[0].next_element for i in pub_date]\n",
    "print(pub_date_list)\n",
    "\n",
    "Data_dict={'PMID':id_list,'Title':title_list,'Date':pub_date_list}\n",
    "# Data_dict\n",
    "pub_df=pd.DataFrame.from_dict(data=Data_dict,orient='index').transpose()\n",
    "print(type(fetch_obj))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PMID</th>\n",
       "      <th>Title</th>\n",
       "      <th>Date</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>35441127</td>\n",
       "      <td>Asymptomatic COVID-19 in the elderly: dementia...</td>\n",
       "      <td>21-04-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>35387044</td>\n",
       "      <td>Review: The Nose as a Route for Therapy. Part ...</td>\n",
       "      <td>08-04-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>35373130</td>\n",
       "      <td>COVID-19 in Patients with Glomerular Disease: ...</td>\n",
       "      <td>07-04-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>35373125</td>\n",
       "      <td>A Propensity Score-Matched Observational Study...</td>\n",
       "      <td>07-04-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>35373088</td>\n",
       "      <td>SARS-CoV-2 Infection Risk Factors among Mainte...</td>\n",
       "      <td>07-04-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>35373072</td>\n",
       "      <td>Evidence for SARS-CoV-2 Spike Protein in the U...</td>\n",
       "      <td>07-04-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>35291567</td>\n",
       "      <td>The effect of the COVID-19 pandemic on influen...</td>\n",
       "      <td>18-03-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>35261474</td>\n",
       "      <td>COVID-19 and the acceleration toward remote ca...</td>\n",
       "      <td>10-03-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>35178046</td>\n",
       "      <td>Immune Reconstitution Following Autologous Hem...</td>\n",
       "      <td>24-02-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>35118329</td>\n",
       "      <td>Systemic treatments for thymic tumors: a narra...</td>\n",
       "      <td>05-02-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>35118328</td>\n",
       "      <td>Targeted therapies for unresectable stage III ...</td>\n",
       "      <td>05-02-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>35111162</td>\n",
       "      <td>B- and T-Cell Responses After SARS-CoV-2 Vacci...</td>\n",
       "      <td>07-02-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>35095257</td>\n",
       "      <td>Development of a Robust Manufacturing Route fo...</td>\n",
       "      <td>01-02-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>35046939</td>\n",
       "      <td>Persistence of Anti-SARS-CoV-2 Antibodies in L...</td>\n",
       "      <td>24-01-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>35039193</td>\n",
       "      <td>COVID-19 and missed or delayed vaccination in ...</td>\n",
       "      <td>18-02-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>35035559</td>\n",
       "      <td>Management of children and adolescents with br...</td>\n",
       "      <td>30-04-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>35035297</td>\n",
       "      <td>The Multiple Sclerosis Data Alliance Catalogue...</td>\n",
       "      <td>30-04-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>35013735</td>\n",
       "      <td>Phylogenetic estimates of SARS-CoV-2 introduct...</td>\n",
       "      <td>30-04-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>33855313</td>\n",
       "      <td>The impact of COVID-19 on oncology professiona...</td>\n",
       "      <td>10-03-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>35007996</td>\n",
       "      <td>COVID-19 Pandemic and Trends in Clinical Trial...</td>\n",
       "      <td>11-01-2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>35004791</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        PMID                                              Title        Date\n",
       "0   35441127  Asymptomatic COVID-19 in the elderly: dementia...  21-04-2022\n",
       "1   35387044  Review: The Nose as a Route for Therapy. Part ...  08-04-2022\n",
       "2   35373130  COVID-19 in Patients with Glomerular Disease: ...  07-04-2022\n",
       "3   35373125  A Propensity Score-Matched Observational Study...  07-04-2022\n",
       "4   35373088  SARS-CoV-2 Infection Risk Factors among Mainte...  07-04-2022\n",
       "5   35373072  Evidence for SARS-CoV-2 Spike Protein in the U...  07-04-2022\n",
       "6   35291567  The effect of the COVID-19 pandemic on influen...  18-03-2022\n",
       "7   35261474  COVID-19 and the acceleration toward remote ca...  10-03-2022\n",
       "8   35178046  Immune Reconstitution Following Autologous Hem...  24-02-2022\n",
       "9   35118329  Systemic treatments for thymic tumors: a narra...  05-02-2022\n",
       "10  35118328  Targeted therapies for unresectable stage III ...  05-02-2022\n",
       "11  35111162  B- and T-Cell Responses After SARS-CoV-2 Vacci...  07-02-2022\n",
       "12  35095257  Development of a Robust Manufacturing Route fo...  01-02-2022\n",
       "13  35046939  Persistence of Anti-SARS-CoV-2 Antibodies in L...  24-01-2022\n",
       "14  35039193  COVID-19 and missed or delayed vaccination in ...  18-02-2022\n",
       "15  35035559  Management of children and adolescents with br...  30-04-2022\n",
       "16  35035297  The Multiple Sclerosis Data Alliance Catalogue...  30-04-2022\n",
       "17  35013735  Phylogenetic estimates of SARS-CoV-2 introduct...  30-04-2022\n",
       "18  33855313  The impact of COVID-19 on oncology professiona...  10-03-2022\n",
       "19  35007996  COVID-19 Pandemic and Trends in Clinical Trial...  11-01-2022\n",
       "20  35004791                                               None        None"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# pub_df.to_csv('./Patent.csv')\n",
    "pub_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
